Processing 00000000.tx.1: Effects of Insulin and Antioxidant on Plasma 8-Hydroxyguanine and Tissue 8-Hydroxydeoxyguanosine in Streptozotocin-Induced Diabetic Rats Kyong Soo Park1,2, Jae Hyeon Kim1, Min Seon Kim1, Jeong Mi Kim3, Suk Kyeong Kim1, Jeong Yun Choi4, Myung Hee Chung4, Boghee Han5, Seong Yeon Kim1, and Hong Kye Lee1,5 1 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea 2 Institute of Endocrinology, Nutrition and Metabolism, Seoul National University Medical Research Center, Seoul, Korea 3 Center for Hormone Research, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea 4 Department of Pharmacology, Seoul National University College of Medicine, Seoul, Korea 5 Department of Biomedical Sciences, National Institute of Health, Seoul, Korea  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Cumulating evidence suggests that enhanced oxidative stress may contribute to diabetic angiopathy. 

Phrase: "Effects of Insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "Antioxidant on Plasma 8-Hydroxyguanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "and"

Phrase: "Tissue 8-Hydroxydeoxyguanosine in Streptozotocin-Induced Diabetic Rats Kyong Soo Park1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Jae Hyeon Kim1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1425141:KIM1 [Gene or Genome]
   827   C2681921:KIM1 [Laboratory Procedure]

Phrase: "Min Seon Kim1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1425141:KIM1 [Gene or Genome]
   827   C2681921:KIM1 [Laboratory Procedure]

Phrase: "Jeong Mi Kim3,"

Phrase: "Suk Kyeong Kim1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1425141:KIM1 [Gene or Genome]
   827   C2681921:KIM1 [Laboratory Procedure]

Phrase: "Jeong Yun Choi4,"

Phrase: "Myung Hee Chung4,"

Phrase: "Boghee Han5,"

Phrase: "Seong Yeon Kim1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1425141:KIM1 [Gene or Genome]
   827   C2681921:KIM1 [Laboratory Procedure]

Phrase: "and"

Phrase: "Hong Kye Lee1,"

Phrase: "5 1 Department of Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "Seoul National University College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0557806:College [Manufactured Object]

Phrase: "Seoul,"

Phrase: "Korea 2 Institute of Endocrinology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "Nutrition"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0028707:Nutrition [Biomedical Occupation or Discipline]
  1000   C0392209:nutrition [Organism Attribute]
  1000   C1442959:Nutrition [Organism Function]
   928 E C1521739:Nutritional [Qualitative Concept]
   928 E C2707262:Nutritional [Clinical Attribute]

Phrase: "and"

Phrase: "Metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "Seoul National University Medical Research Center,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   867   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   839   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   839   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0683939:research center [Manufactured Object,Organization]
   799   C0205099:Center [Spatial Concept]

Phrase: "Seoul,"

Phrase: "Korea 3 Center for Hormone Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0683939:center research [Manufactured Object,Organization]
   753   C0205099:Center [Spatial Concept]

Phrase: "Clinical Research Institute,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0008972:Clinical Research [Research Activity]
   901   C0035172:Research Institute [Organization]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0205210:Clinical [Qualitative Concept]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "Seoul National University Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1510665:Hospital [Qualitative Concept]
   812   C3245503:national [Intellectual Product]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "Seoul,"

Phrase: "Korea 4 Department of Pharmacology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Seoul National University College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0557806:College [Manufactured Object]

Phrase: "Seoul,"

Phrase: "Korea 5 Department of Biomedical Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "National Institute of Health,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C0027468:health national institute [Health Care Related Organization]
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Seoul,"

Phrase: "Korea  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cumulating evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that enhanced oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "may"

Phrase: "contribute to diabetic angiopathy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0011875:Diabetic angiopathy [Disease or Syndrome]
   770   C0042373:Angiopathy [Disease or Syndrome]
   770   C0241863:DIABETIC [Finding]
   770   C1880177:Contribute [Activity]
Processing 00000000.tx.2: The levels of 8-hydroxydeoxyguanosine (8-OHdG) and 8-hydroxyguanine (8-OHG), indicators of oxidative DNA damage, in tissue or body fluid are increased in diabetic patients. 

Phrase: "The levels of 8-hydroxydeoxyguanosine (8-OHdG)"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "8-hydroxyguanine (8-OHG),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "indicators of oxidative DNA damage,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0021212:Indicators [Indicator, Reagent, or Diagnostic Aid]
   726 E C1235732:Indicator [Bird]
   726 E C1522602:Indicator [Functional Concept]

Phrase: "in tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "or"

Phrase: "body fluid"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0005889:Body fluid [Body Substance]
           FLUID
   861   C0242821:body [Human]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1704353:Fluid [Substance]
   777 E C1995017:Bodies [Cell Component]

Phrase: "are"

Phrase: "increased in diabetic patients."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205217:Increased [Quantitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0442805:Increased [Functional Concept]
Processing 00000000.tx.3: However, it is unclear whether plasma 8-OHG correlates with tissue 8-OHdG and whether insulin or antioxidant treatment reduces plasma 8-OHG in diabetic state. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "unclear"

Phrase: "whether"

Phrase: "plasma 8-OHG correlates with tissue 8-OHdG"

Phrase: "and"

Phrase: "whether"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "antioxidant treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "reduces"

Phrase: "plasma 8-OHG in diabetic state."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.4: In this study, we measured the 8-OHG levels in plasma as well as the 8-OHdG levels in liver and kidney in streptozotocin-induced diabetic rats (DR) treated with insulin (DR+I), insulin and probucol (DR+I/P), or insulin and vitamin E (DR+I/E). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the 8-OHG levels in plasma"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "as well as"

Phrase: "the 8-OHdG levels in liver"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "kidney in streptozotocin-induced diabetic rats (DR)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1882714:Rat Kidney [Body Part, Organ, or Organ Component]
   753   C0022646:Kidney [Body Part, Organ, or Organ Component]
   753   C0227665:kidney [Body Part, Organ, or Organ Component]
   753   C1278978:Kidney [Body Part, Organ, or Organ Component]
   753   C1514845:KIDNEY [Tissue]

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(DR+I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "probucol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033215:Probucol [Organic Chemical,Pharmacologic Substance]

Phrase: "(DR+I/P),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "vitamin E"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   944 E C0591450:Ephynal [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "(DR+I/E)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.5: There was a correlation between plasma 8-OHG levels and tissue 8-OHdG levels (plasma 8-OHG vs. liver 8-OHdG: r = 0.64, P < 0.001; 

Phrase: "There"

Phrase: "was"

Phrase: "a correlation between plasma 8-OHG levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "tissue 8-OHdG levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "vs. liver 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "r = 0.64,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.6: plasma 8-OHG vs. kidney 8-OHdG: r = 0.38, P = 0.06). 

Phrase: "plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "vs. kidney 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "r = 0.38,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P = 0.06"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.7: DR had levels of plasma 8-OHG that were three times higher than control rats (CR), whereas they had levels of tissue 8-OHdG that were 1.52 times higher. 

Phrase: "DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "had"

Phrase: "levels of plasma 8-OHG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "were"

Phrase: "three times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "higher than control rats (CR),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "whereas"

Phrase: "they"

Phrase: "had"

Phrase: "levels of tissue 8-OHdG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "were"

Phrase: "1.52 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "higher."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]
Processing 00000000.tx.8: Plasma 8-OHG levels in DR were almost normalized by insulin treatment, although insulin partially corrected hyperglycemia (plasma 8-OHG: CR 3.3  2.7 pmol/ml; 

Phrase: "Plasma 8-OHG levels in DR"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "almost"

Phrase: "normalized by insulin treatment,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C1882115:Normalized [Research Activity]
   770   C3538994:TREATMENT [Research Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "although"

Phrase: "insulin partially corrected hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "(plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "CR 3.3  2.7 pmol/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439282:pmol/mL [Quantitative Concept]
   793   C0439526:/mL [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.9: DR 10.4  2.3 pmol/ml, P < 0.05 vs. 

Phrase: "DR 10.4  2.3 pmol/ml,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   866   C1883313:10^3/mL [Quantitative Concept]
   866   C3642200:10^2/mL [Quantitative Concept]
   812   C0439282:pmol/mL [Quantitative Concept]
   793   C0439526:/mL [Quantitative Concept]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.10: CR; 

Phrase: "CR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.11: DR with insulin 3.6  1.0 pmol/ml, P < 0.05 vs. 

Phrase: "DR with insulin 3.6  1.0 pmol/ml,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0421248:diabetic insulin [Finding]
   741   C1514732:Rat-1 [Cell]
   739   C0034693:rats [Mammal]
   739   C0034721:Rats [Mammal]
   739   C0241863:DIABETIC [Finding]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.12: DR). 

Phrase: "DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: ")."
Processing 00000000.tx.13: However, tissue 8-OHdG levels in DR were significantly decreased by combined treatment with insulin and antioxidant (probucol or vitamin E), but not by insulin treatment alone. 

Phrase: "However,"

Phrase: "tissue 8-OHdG levels in DR"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "decreased by combined treatment"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   833   C0009429:combined treatment [Therapeutic or Preventive Procedure]
   833   C1704537:Combined Treatment [Therapeutic or Preventive Procedure]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205195:Combined [Qualitative Concept]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0336789:Combine [Manufactured Object]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "antioxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "(probucol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033215:Probucol [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "vitamin E"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   944 E C0591450:Ephynal [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not by insulin treatment"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1518422:Not [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.14: This data suggests that plasma 8-OHG could be a useful biomarker of oxidative DNA damage in diabetic subjects. 

Phrase: "This data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "could"

Phrase: "be"

Phrase: "a useful biomarker of oxidative DNA damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0005516:Biomarker [Clinical Attribute]

Phrase: "in diabetic subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.15: The mechanism of differential response of plasma 8-OHG and tissue 8-OHdG to insulin and antioxidant treatment remains to be elucidated.  

Phrase: "The mechanism of differential response of plasma 8-OHG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "tissue 8-OHdG to insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "antioxidant treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.16: INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  A role of reactive oxygen species (ROS) has been demonstrated as a cause of type 1 diabetes induced by chemicals such as alloxan and streptozotocin (STZ) in experimental animals (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A role of reactive oxygen species (ROS)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated as a cause of type 1 diabetes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0011854:Type 1 diabetes [Disease or Syndrome]
   770   C0441729:Type 1 [Classification]
   767   C1320657:Diabetes type [Finding]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0015127:cause [Functional Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C1524003:Cause [Conceptual Entity]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "induced by chemicals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205263:Induced [Functional Concept]
   790   C0220806:Chemicals [Chemical]
   756 E C3272558:Chemical [Intellectual Product]

Phrase: "such as alloxan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002151:Alloxan [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "streptozotocin (STZ) in experimental animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: However, not only are oxygen radicals involved in the cause, but diabetic status itself is associated with increased production of ROS, and this condition in turn has been suggested as one of the pathogenic mechanisms of diabetic complications (2,3). 

Phrase: "However,"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "are"

Phrase: "oxygen radicals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0162772:Oxygen Radicals [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0302912:radicals [Chemical Viewed Structurally]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "involved in the cause,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015127:cause [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1524003:Cause [Conceptual Entity]

Phrase: "but"

Phrase: "diabetic status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]

Phrase: "itself"

Phrase: "is"

Phrase: "associated with increased production of ROS,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   782   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0332281:Associated with [Qualitative Concept]
           Associated
   739   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C0033268:production [Occupational Activity]
   739   C0035820:Role [Social Behavior]
   739   C0205217:Increased [Quantitative Concept]
   739   C0205332:Reactive [Qualitative Concept]
   739   C0442805:Increased [Functional Concept]
   739   C1705810:Role [Conceptual Entity]
   739   C1705920:Species [Conceptual Entity]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "this condition in turn"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   755 E C0009647:Conditioned [Mental Process]
   755 E C1701901:Conditional [Qualitative Concept]
   755 E C1963686:Conditional [Functional Concept]
   727 E C1519605:Conditionality [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "suggested as one of the pathogenic mechanisms of diabetic complications"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0342257:Diabetic Complications [Pathologic Function]
   739   C0009566:Complications [Pathologic Function]
   739   C0205447:One [Quantitative Concept]
   739   C0241863:DIABETIC [Finding]
   739   C0441712:Mechanisms [Functional Concept]
   739   C0450254:Pathogenic [Organism]
   739   C1171258:complications [Pathologic Function]
   706   C1705535:Suggest [Idea or Concept]
   706 E C1706376:Mechanism [Manufactured Object]
   706 E C2362589:Complication [Idea or Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.18: A recent study has shown that blockade of hyperglycemia-induced ROS production reverses the pathways implicated in diabetic angiopathy: activation of protein kinase C, formation of advanced glycation end product, and elevated sorbitol content in cultured endothelial cells (4). 

Phrase: "A recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that blockade of hyperglycemia-induced ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0332206:Blockade [Functional Concept]
   738   C3540676:Blockade [Pharmacologic Substance]

Phrase: "reverses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "the pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "implicated in diabetic angiopathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0011875:Diabetic angiopathy [Disease or Syndrome]
   770   C0042373:Angiopathy [Disease or Syndrome]
   770   C0241863:DIABETIC [Finding]

Phrase: ":"

Phrase: "activation of protein kinase C,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   900   C3546691:protein kinase C activation [Molecular Function]
   844   C1819041:protein kinase activation [Cell Function]
   797   C0599177:protein activation [Genetic Function]
   760   C1879547:Activation [Activity]

Phrase: "formation of advanced glycation end product,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "elevated sorbitol content in cultured endothelial cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.19: It suggests that enhanced ROS production in diabetes may be a common pathway linking diverse pathogenic mechanisms of diabetic vascular complications. 

Phrase: "It"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that enhanced ROS production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
   731   C0150325:Role enhancement [Therapeutic or Preventive Procedure]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "may"

Phrase: "be"

Phrase: "a common pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "diverse pathogenic mechanisms of diabetic vascular complications."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.20: Therefore, assessment of oxidative stress in diabetic patients may be important for the prediction and prevention of diabetic complications. 

Phrase: "Therefore,"

Phrase: "assessment of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261322:Assessment [Health Care Activity]
   770   C1516048:Assessment [Activity]

Phrase: "in diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "may"

Phrase: "be"

Phrase: "important for the prediction"

Phrase: "and"

Phrase: "prevention of diabetic complications."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   881   C0547286:prevention of complications [Therapeutic or Preventive Procedure]
           prevention complications
   770   C0199176:Prevention [Therapeutic or Preventive Procedure]
   770   C1706420:PREVENTION [Research Activity]
   770   C2700409:prevention [Qualitative Concept]
Processing 00000000.tx.21: A direct measurement of ROS production in target organs is not currently possible in vivo. 

Phrase: "A direct measurement of ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0523806:Oxygen measurement [Laboratory Procedure]
   739   C0242485:Measurement [Functional Concept]

Phrase: "in target organs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0178784:organs [Body Part, Organ, or Organ Component]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]

Phrase: "is"

Phrase: "not currently possible in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.22: However, it can be indirectly assessed by measurement of oxidative products because ROS, which is an inherently unstable molecule because of an unpaired electron, undergoes a series of interactions with biological macromolecules such as lipids, proteins, and DNA (5). 

Phrase: "However,"

Phrase: "it"

Phrase: "can"

Phrase: "be"

Phrase: "indirectly"

Phrase: "assessed by measurement of oxidative products"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0242485:Measurement [Functional Concept]
   753   C0311404:Oxidative [Functional Concept]
   753   C1514468:Products [Entity]
   753   C1516048:Assessed [Activity]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "because"

Phrase: "ROS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "which"

Phrase: "is"

Phrase: "an inherently unstable molecule because of an unpaired electron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0314669:Unstable molecule [Molecular Function]
   742   C0567416:Molecule [Substance]

Phrase: "undergoes"

Phrase: "a series of interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205549:Series [Quantitative Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: "with biological macromolecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1179809:Biological macromolecule [Substance]
   861   C0178735:macromolecules [Chemical Viewed Structurally]

Phrase: "such as lipids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.23: In the diabetic state, the levels of markers for lipid peroxidation (e.g., malondialdehyde and thiobarbituric acidreactive substances) and protein oxidation [e.g., N-(carboxymethyl)-lysine, N-(carboxymethyl)-hydroxylysine, and pentosidine] are elevated (6). 

Phrase: "In the diabetic state,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0241863:DIABETIC [Finding]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "the levels of markers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "for lipid peroxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023775:Lipid Peroxidation [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0178796:peroxidation [Phenomenon or Process]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "malondialdehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024643:Malondialdehyde [Organic Chemical]

Phrase: "and"

Phrase: "thiobarbituric acidreactive substances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439861:Substances [Substance]

Phrase: ")"

Phrase: "and"

Phrase: "protein oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1159301:protein oxidation [Molecular Function]
   861   C0030011:Oxidation [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "["

Phrase: "e.g."

Phrase: ","

Phrase: "N-(carboxymethyl)-lysine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0083528:carboxymethyl-lysine [Amino Acid, Peptide, or Protein]
   827   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "N-(carboxymethyl"

Phrase: ")-"

Phrase: "hydroxylysine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020366:Hydroxylysine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "pentosidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070317:pentosidine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "]"

Phrase: "are"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.24: As a biomarker for oxidative DNA damage, 8-hydroxydeoxyguanosine (8-OHdG) in tissue or body fluid is known as a sensitive indicator (7,8,9). 

Phrase: "As a biomarker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Biomarker [Clinical Attribute]

Phrase: "for oxidative DNA damage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   827   C0010957:Damage [Injury or Poisoning]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1883709:Damage [Functional Concept]

Phrase: "8-hydroxydeoxyguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "in tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "or"

Phrase: "body fluid"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0005889:Body fluid [Body Substance]
           FLUID
   861   C0242821:body [Human]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1704353:Fluid [Substance]
   777 E C1995017:Bodies [Cell Component]

Phrase: "is"

Phrase: "known as a sensitive indicator"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   760   C0205309:Known [Qualitative Concept]
   760   C0332324:Sensitive [Functional Concept]
   760   C1235732:Indicator [Bird]
   760   C1522602:Indicator [Functional Concept]
   760   C1550474:sensitive [Idea or Concept]

Phrase: "(7,"

Phrase: "8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.25: 8-OHdG, a major product of oxidative DNA damage, is produced by enzymatic cleavage after 8-hydroxylation of the guanine base of DNA (10,11,12). 

Phrase: "8-OHdG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "a major product of oxidative DNA damage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]

Phrase: "is"

Phrase: "produced by enzymatic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "after 8-hydroxylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020365:Hydroxylation [Natural Phenomenon or Process]

Phrase: "of the guanine base"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "of DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(10,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.26: Because 8-OHdG is an unstable molecule, it is further hydrolyzed to 8-hydroxyguanine (8-OHG), and both 8-OHdG and 8-OHG are released into systemic circulation and secreted in urine. 

Phrase: "Because"

Phrase: "8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "an unstable molecule,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0314669:Unstable molecule [Molecular Function]
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "hydrolyzed to 8-hydroxyguanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "both 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "released into systemic circulation"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0005775:Circulation [Physiologic Function]
   770   C0205373:Systemic [Functional Concept]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1516559:Circulation [Organism Function]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "secreted in urine."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0042036:Urine [Body Substance]
   790   C0042037:urine [Functional Concept]
   790   C1327616:Secreted [Cell Function]
   790   C2963137:Urine [Body Substance]
Processing 00000000.tx.27: Previous studies have shown that diabetic patients have higher levels of 8-OHdG in the mononuclear cells and urine (13,14,15). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "higher levels of 8-OHdG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the mononuclear cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0806987:Mononuclear cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1513475:Mononuclear [Clinical Attribute]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "(13,"

Phrase: "14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.28: Moreover, kidney 8-OHdG levels in STZ-induced diabetic rats (DR) is increased and reduced by insulin treatment (16). 

Phrase: "Moreover,"

Phrase: "kidney 8-OHdG levels in STZ-induced diabetic rats"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "(DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: ")"

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "reduced by insulin treatment"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0392756:Reduced [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.29: However, measurement of 8-OHdG has been hampered by the risk of auto-oxidation of deoxyguanosine (dG) during the preparation of a sample as well as during the work-up procedure for high-performance liquid chromatography (HPLC), resulting in false-high background and low sensitivity (17). 

Phrase: "However,"

Phrase: "measurement of 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "hampered by the risk of auto-oxidation of deoxyguanosine (dG)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   742   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0030011:Oxidation [Molecular Function]
   742   C0035647:Risk [Qualitative Concept]
   742   C1441488:Auto [Laboratory Procedure]

Phrase: "during the preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of a sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "as well as during the work-up procedure"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0750430:Work-up [Diagnostic Procedure]
   744   C0043227:Work [Occupational Activity]
   744   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   744   C0205170:Well [Qualitative Concept]
   744   C1948041:Procedure [Therapeutic or Preventive Procedure]
   744   C2700391:Procedure [Activity]
   744   C3146287:Well [Manufactured Object]
   744   C3274430:PROCEDURE [Health Care Activity]
   744   C3538935:Procedure [Idea or Concept]
   744   C3539779:Procedure [Intellectual Product]

Phrase: "for high-performance liquid chromatography (HPLC),"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
  1000   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
  1000   C1579831:High performance liquid chromatography [Functional Concept]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0597198:Performance [Individual Behavior]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C1882330:Performance [Activity]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]

Phrase: "resulting in false-high background"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0332294:Resulting in [Functional Concept]
   760   C0205237:False [Qualitative Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0678226:resulting [Functional Concept]
   760   C1299351:High [Qualitative Concept]
   760   C1706907:Background [Conceptual Entity]
   760   C2700149:HIGH [Intellectual Product]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "low sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.30: Measurement of plasma 8-OHG may provide a more accurate and stable assay for oxidative DNA damage because 8-OHG is not affected by the work-up procedure (18). 

Phrase: "Measurement of plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:Measurement [Functional Concept]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a more accurate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443131:Accurate [Qualitative Concept]

Phrase: "and"

Phrase: "stable assay for oxidative DNA damage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "because"

Phrase: "8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by the work-up procedure"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0750430:Work-up [Diagnostic Procedure]
   753   C0043227:Work [Occupational Activity]
   753   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C0392760:Affected [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   753   C1948041:Procedure [Therapeutic or Preventive Procedure]
   753   C2700391:Procedure [Activity]
   753   C3274430:PROCEDURE [Health Care Activity]
   753   C3538935:Procedure [Idea or Concept]
   753   C3539779:Procedure [Intellectual Product]
   719 E C0001721:Affect [Mental Process]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.31: However, it is unclear whether serum 8-OHG could be a good indicator reflecting oxidative DNA damage in tissue. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "unclear"

Phrase: "whether"

Phrase: "serum 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "could"

Phrase: "be"

Phrase: "a good indicator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   861   C1235732:Indicator [Bird]
   861   C1522602:Indicator [Functional Concept]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "oxidative DNA damage in tissue."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   797   C0010957:Tissue damage [Injury or Poisoning]
           Damage
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1883709:Damage [Functional Concept]
Processing 00000000.tx.32: Moreover, there is little data regarding 8-OHG in the diabetic state. 

Phrase: "Moreover,"

Phrase: "there"

Phrase: "is"

Phrase: "little data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "regarding"

Phrase: "8-OHG in the diabetic state."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.33: In this study, we investigated a correlation between plasma 8-OHG and tissue 8-OHdG in male Sprague-Dawley rats. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "a correlation between plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "tissue 8-OHdG in male Sprague-Dawley rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.34: For the measurement of 8-OHG and 8-OHdG, we applied HPLC with electrochemical detection, which is the most sensitive and reliable method (18,19). 

Phrase: "For the measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "of 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "8-OHdG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "HPLC with electrochemical detection,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   853   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   853   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   853   C1579831:High performance liquid chromatography [Functional Concept]
   778   C0008565:Liquid Chromatography [Laboratory Procedure]
   748   C0008550:Chromatography [Laboratory Procedure]
   748   C0205250:High [Qualitative Concept]
   748   C0302908:Liquid [Substance]
   748   C0597198:Performance [Individual Behavior]
   748   C1299351:High [Qualitative Concept]
   748   C1304698:Liquid [Finding]
   748   C1546699:Liquid NOS [Intellectual Product]
   748   C1561501:Liquid NOS [Substance]
   748   C1882330:Performance [Activity]
   748   C2700149:HIGH [Intellectual Product]

Phrase: "which"

Phrase: "is"

Phrase: "the most sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "reliable method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.35: We also investigated the effects of insulin and antioxidant (vitamin E and probucol) treatment on oxidative DNA damage in STZ-induced DR, using plasma 8-OHG and tissue 8-OHdG as biomarkers.  

Phrase: "We also"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "antioxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "(vitamin E"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   944 E C0591450:Ephynal [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "probucol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033215:Probucol [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "treatment on oxidative DNA damage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "in STZ-induced DR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "tissue 8-OHdG as biomarkers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.36: RESEARCH DESIGN AND METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Animals. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0086912:methods research [Research Activity]
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]
Processing 00000000.tx.37: Male 7-week-old Sprague-Dawley rats were obtained from Daehan Laboratory Animal Research (Seoul, Korea). 

Phrase: "Male 7-week-old Sprague-Dawley rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0034715:Rats, Sprague-Dawley [Mammal]
   818   C2699239:Sprague-Dawley [Mammal]
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "obtained from Daehan Laboratory Animal Research"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0003048:Animal Research [Research Activity]
   790   C0003064:Laboratory Animal [Animal]
   783   C0022886:Laboratory Research [Research Activity]
   753   C0003062:Animal [Animal]
   753   C0022877:Laboratory [Manufactured Object,Organization]
   753   C0035168:research [Research Activity]
   753   C0242481:Research [Research Activity]
   753   C1301820:Obtained [Functional Concept]
   753   C3244292:laboratory [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "(Seoul,"

Phrase: "Korea"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: ")."
Processing 00000000.tx.38: Animals were maintained under controlled temperature (2123C) and light (12:12 h light:dark cycle, lights on at 7:00 A.M.), with ad libitum access to food and water. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "under controlled temperature"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0449862:Controlled temperature [Phenomenon or Process]
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]

Phrase: "(2123C"

Phrase: ")"

Phrase: "and"

Phrase: "light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023693:Light [Natural Phenomenon or Process]
  1000   C1306462:Light [Functional Concept]
  1000   C1881376:Light [Qualitative Concept]

Phrase: "(12"

Phrase: ":"

Phrase: "12 h light:dark cycle,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C2718082:Light-Dark Cycle [Temporal Concept]
           Light Cycle
   804   C0023693:Light [Natural Phenomenon or Process]
   804   C0332582:Dark [Qualitative Concept]
   804   C1306462:Light [Functional Concept]
   804   C1511572:Cycle [Temporal Concept]
   804   C1881376:Light [Qualitative Concept]

Phrase: "lights on"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C0023693:lights [Natural Phenomenon or Process]
   799 E C1306462:Light [Functional Concept]
   799 E C1881376:Light [Qualitative Concept]

Phrase: "at 7"

Phrase: ":"

Phrase: "00 A.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "with ad libitum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879743:ad libitum [Qualitative Concept]

Phrase: "access to food"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016452:Food [Food]
   790   C0444454:Access [Spatial Concept]
   790   C1554204:access [Idea or Concept]

Phrase: "and"

Phrase: "water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.39: Experimental protocols. 

Phrase: "Experimental protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.40: Diabetes in rats was induced by a single intraperitoneal injection of 60 mg/kg STZ (Sigma, St Louis, MO), as previously described (16). 

Phrase: "Diabetes in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]

Phrase: "was"

Phrase: "induced by a single intraperitoneal injection of 60 mg/kg STZ"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   756   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   756   C0439272:mg kg [Quantitative Concept]
   738   C0021485:injection [Therapeutic or Preventive Procedure]
   738   C0022718:KG [Geographic Area]
   738   C0037179:Single [Population Group]
   738   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   738   C0087136:single [Finding]
   738   C0205171:Single [Quantitative Concept]
   738   C0205263:Induced [Functional Concept]
   738   C0439209:kg [Quantitative Concept]
   738   C0439269:mg% [Quantitative Concept]
   738   C0442120:Intraperitoneal [Spatial Concept]
   738   C1272883:Injection [Biomedical or Dental Material]
   738   C1533685:Injection [Therapeutic or Preventive Procedure]
   738   C1828121:Injection [Functional Concept]
   738   C1960952:mg % [Quantitative Concept]
   738   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.41: STZ was dissolved in 2.5 ml/kg citrate buffer (pH 4.5) just before injection. 

Phrase: "STZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "was"

Phrase: "dissolved in 2.5 ml/kg citrate buffer"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C1300574:mL/kg [Quantitative Concept]
   770   C3256468:citrate buffer [Pharmacologic Substance]
   767 E C1881001:kg/mL [Quantitative Concept]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0008857:Citrate [Organic Chemical]
   744   C0022718:KG [Geographic Area]
   744   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   744   C0439209:kg [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   711   C1549535:Dissolve [Functional Concept]

Phrase: "(pH 4.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2678549:PH-4 [Gene or Genome]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "just"

Phrase: "before"

Phrase: "injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]
Processing 00000000.tx.42: Rats in the control group (CR) (n = 7) received an intraperitoneal injection of an equal volume of citrate buffer instead of STZ. 

Phrase: "Rats in the control group"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]

Phrase: "(CR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "(n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "an intraperitoneal injection of an equal volume of citrate buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   757   C0941280:Injection volume [Quantitative Concept]
   739   C0021485:injection [Therapeutic or Preventive Procedure]
   739   C0442120:Intraperitoneal [Spatial Concept]
   739   C1272883:Injection [Biomedical or Dental Material]
   739   C1533685:Injection [Therapeutic or Preventive Procedure]
   739   C1828121:Injection [Functional Concept]

Phrase: "instead of STZ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
Processing 00000000.tx.43: At 48 h after STZ injection, blood samples were obtained from the tail vein, and blood glucose concentrations were measured with a Surestep glucometer (Lifescan, Milpitas, CA). 

Phrase: "At 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "after STZ injection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "obtained from the tail vein,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C2985205:Tail Vein [Body Part, Organ, or Organ Component]
   760   C0039259:Tail [Body Part, Organ, or Organ Component]
   760   C0042449:Vein [Body Part, Organ, or Organ Component]
   760   C1278960:Vein [Body Part, Organ, or Organ Component]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "blood glucose concentrations"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   983   C2585282:Blood glucose concentration [Finding]
   913   C0427728:blood concentrations [Laboratory or Test Result]
   913   C0699870:blood concentrations [Quantitative Concept]
   913   C1313904:blood concentrations [Laboratory Procedure]
   884   C0427743:Glucose concentration [Laboratory Procedure]
   884   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0005802:Blood Glucose [Carbohydrate]

Phrase: "were"

Phrase: "measured with a Surestep glucometer"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0444706:Measured [Qualitative Concept]
   760   C0472226:Glucometer [Medical Device]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "(Lifescan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470941:lifescan [Health Care Related Organization]

Phrase: "Milpitas,"

Phrase: "CA)."
Processing 00000000.tx.44: Successful induction of diabetes was defined as a blood glucose level of >11.1 mmol/l. 

Phrase: "Successful induction of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "as a blood glucose level of >11.1 mmol/l."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1532563:mmol/L [Quantitative Concept]
Processing 00000000.tx.45: On day 3 postSTZ treatment, DR were randomly assigned to four groups (n = 67 each group): diabetes with no treatment (DR), diabetes with insulin treatment (DR+I), diabetes with insulin and probucol treatment (DR+I/P), or diabetes with insulin and vitamin E treatment (DR+I/E). 

Phrase: "On day 3 postSTZ treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "were"

Phrase: "randomly"

Phrase: "assigned to four groups"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0205450:Four [Quantitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1516050:Assigned [Functional Concept]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552601:assigned [Intellectual Product]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "(n = 67"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "each group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: ")"

Phrase: ":"

Phrase: "diabetes with no treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: ")"

Phrase: ","

Phrase: "diabetes with insulin treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(DR+I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "diabetes with insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "probucol treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(DR+I/P),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "diabetes with insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "vitamin E treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]

Phrase: "(DR+I/E)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.46: For insulin-treated groups, intermediate-acting insulin (Insulatard, Novo Nordisk, Copenhagen) was administered subcutaneously once a day (at 4:00 P.M.) 

Phrase: "For insulin-treated groups,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   827   C0332293:treated [Therapeutic or Preventive Procedure]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1522326:Treated [Functional Concept]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   793 E C1292734:TREAT [Functional Concept]

Phrase: "intermediate-acting insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0304869:Intermediate-acting insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Insulatard,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0307071:insulatard [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "Novo Nordisk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331875:Novo Nordisk [Health Care Related Organization]

Phrase: "Copenhagen"

Phrase: ")"

Phrase: "was"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "subcutaneously once"

Phrase: "a day"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332173:/day [Temporal Concept]
  1000   C0439228:day [Temporal Concept]
  1000   C0439505:/day [Temporal Concept]

Phrase: "("

Phrase: "at 4"

Phrase: ":"

Phrase: "00 P.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: ")"
Processing 00000000.tx.47: until the animals were killed. 

Phrase: "until the animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "killed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]
Processing 00000000.tx.48: Blood glucose levels were measured every other day, just before insulin injection. 

Phrase: "Blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "every other day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332173:/day [Temporal Concept]
  1000   C0439228:day [Temporal Concept]
  1000   C0439505:/day [Temporal Concept]

Phrase: "just"

Phrase: "before"

Phrase: "insulin injection."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0199782:Insulin injection [Therapeutic or Preventive Procedure]
  1000   C0586328:Insulin injection [Therapeutic or Preventive Procedure]
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1828121:Injection [Functional Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.49: The doses of insulin were adjusted to reach target blood glucose levels of 11.1 to 16.7 mmol/l. 

Phrase: "The doses of insulin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0178602:Doses [Quantitative Concept]
   737 E C0869039:Dose [Quantitative Concept]
   737 E C1114758:Dose # [Clinical Attribute]
   737 E C1428722:DOS [Gene or Genome]

Phrase: "were"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "target blood glucose levels of 11.1"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   814   C0428554:blood glucose levels [Laboratory or Test Result]
   778   C0005802:Blood Glucose [Carbohydrate]
   778   C0428548:glucose levels [Laboratory or Test Result]
   757   C0456947:Level 1 [Intellectual Product]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0229664:Blood [Body Substance]
   748   C0441889:Levels [Qualitative Concept]
   745 E C0337438:glucose level [Laboratory Procedure]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "to 16.7 mmol/l."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532563:mmol/L [Quantitative Concept]
Processing 00000000.tx.50: Probucol-treated rats had probucol (1% of food weight)-containing diet, and vitamin Etreated animals had vitamin E (100 IU/kg food weight)-enriched diets for 4 weeks. 

Phrase: "Probucol-treated rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "had"

Phrase: "probucol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033215:Probucol [Organic Chemical,Pharmacologic Substance]

Phrase: "(1% of food weight"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0005910:weight [Organism Attribute]
   770   C0016452:Food [Food]
   770   C0043100:Weight [Quantitative Concept]
   770   C1305866:weight [Diagnostic Procedure]
   770   C1705104:Weight [Idea or Concept]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: ")-"

Phrase: "containing diet,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0012155:Diet [Food]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]

Phrase: "and"

Phrase: "vitamin Etreated animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "had"

Phrase: "vitamin E"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   944 E C0591450:Ephynal [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "(100 IU/kg food weight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0005910:weight [Organism Attribute]
   804   C0043100:Weight [Quantitative Concept]
   804   C1305866:weight [Diagnostic Procedure]
   804   C1705104:Weight [Idea or Concept]

Phrase: ")-"

Phrase: "enriched diets for 4 weeks."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0012155:Diets [Food]
   726 E C1442959:Diet [Organism Function]
   726 E C1519433:DIET [Therapeutic or Preventive Procedure]
   726 E C2983588:DIET [Food]
Processing 00000000.tx.51: On day 28, rats were anesthetized with ether, and blood was obtained from the inferior vena cava. 

Phrase: "On day 28,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "anesthetized with ether,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0014994:Ether [Organic Chemical,Pharmacologic Substance]
   790   C0014996:Ether, NOS [Organic Chemical,Pharmacologic Substance]
   790   C1161324:ether [Organic Chemical,Pharmacologic Substance]
   790   C1720436:Anesthetized [Finding]

Phrase: "and"

Phrase: "blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "obtained from the inferior vena cava."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   833   C0042458:Vena Cava, Inferior [Body Part, Organ, or Organ Component]
   833   C1269024:Inferior vena cava [Body Part, Organ, or Organ Component]
   797 E C0521360:Inferior vena caval [Body Location or Region]
   790   C0042460:Vena cava [Body Part, Organ, or Organ Component]
   790   C1280190:Vena cava [Body Part, Organ, or Organ Component]
   753   C0447122:Vena [Body Part, Organ, or Organ Component]
   753   C0521083:Kava [Plant]
   753   C0542339:Inferior [Spatial Concept]
   753   C0678975:inferior [Social Behavior]
   753   C0939882:KAVA [Organic Chemical,Pharmacologic Substance]
   753   C1301820:Obtained [Functional Concept]
   753   C1413046:CAVA [Gene or Genome]
   753   C1547290:Kava [Intellectual Product]
   719 E C1706701:Obtain [Activity]
Processing 00000000.tx.52: Plasma was separated by centrifugation (1,500 rpm) for 15 min at 4C and stored at -70C. 

Phrase: "Plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "was"

Phrase: "separated by centrifugation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "(1,500 rpm) for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0582523:rpm [Quantitative Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -70C."
Processing 00000000.tx.53: Liver and kidney were quickly removed and stored at -70C until DNA was extracted. 

Phrase: "Liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "were"

Phrase: "quickly"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -70C until DNA"

Phrase: "was"

Phrase: "extracted."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]
Processing 00000000.tx.54: Measurement of tissue 8-OHdG. 

Phrase: "Measurement of tissue 8-OHdG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.55: Liver and kidney DNA was extracted using DNA extractor WB kit (Wako, Osaka, Japan). 

Phrase: "Liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "kidney DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DNA extractor WB kit (Wako,"

Phrase: "Osaka,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.56: The tissue 8-OHdG level was measured using the method described by Shigenaga et al. 

Phrase: "The tissue 8-OHdG level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "described by Shigenaga et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.57: (20) and was expressed as a relative amount per 105 dG. 

Phrase: "(20"

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "expressed as a relative amount"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1265611:Amount [Quantitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "per 105 dG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.58: To avoid the auto-oxidation of 8-OHdG during the experimental procedure, all solutions were saturated with argon gas, and all tubes were flushed with argon gas just before use. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "the auto-oxidation of 8-OHdG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   753   C0030011:Oxidation [Molecular Function]
   753   C1441488:Auto [Laboratory Procedure]

Phrase: "during the experimental procedure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "all solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "saturated with argon gas,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0003781:Argon [Element, Ion, or Isotope]
   770   C0017110:Gas [Chemical Viewed Structurally]
   770   C0522534:Saturated [Phenomenon or Process]
   770   C0596601:Gas [Sign or Symptom]
   770   C1705188:SATURATED [Quantitative Concept]
   770   C1948015:Argon [Eukaryote]

Phrase: "and"

Phrase: "all tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0175730:tubes [Medical Device]
  1000   C1547937:Tubes [Intellectual Product]
  1000   C1704474:Tubes [Quantitative Concept]
   966 E C1561954:tube [Conceptual Entity]
   966 E C1704730:TUBE [Medical Device]

Phrase: "were"

Phrase: "flushed with argon gas just"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0003781:Argon [Element, Ion, or Isotope]
   760   C0016382:flushed [Sign or Symptom]
   760   C0017110:Gas [Chemical Viewed Structurally]
   760   C0596601:Gas [Sign or Symptom]
   760   C1948015:Argon [Eukaryote]
   726 E C1696091:Flush [Functional Concept]

Phrase: "before"

Phrase: "use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.59: Measurement of plasma 8-OHG. 

Phrase: "Measurement of plasma 8-OHG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.60: Determination of plasma 8-OHG levels was performed using the method of Park et al. 

Phrase: "Determination of plasma 8-OHG levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the method of Park et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.61: (21). 

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.62: For the measurement of plasma 8-OHG, 1 ml plasma was spiked with 1,000 cpm [14C]-OHG. 

Phrase: "For the measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "of plasma 8-OHG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "1 ml plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "was"

Phrase: "spiked with 1,000 cpm [14C"

Phrase: "]-OHG."
Processing 00000000.tx.63: Plasma protein was precipitated by the addition of an equal volume of acetonitrile, and precipitated protein was separated by centrifugation at 3,000g for 15 min at 4C. 

Phrase: "Plasma protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0032105:Plasma [Body Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "was"

Phrase: "precipitated by the addition of an equal volume of acetonitrile,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   739   C0050456:acetonitrile [Organic Chemical]
   739   C0205163:Equal [Qualitative Concept]
   739   C0449468:*Volume [Quantitative Concept]
   739   C1549782:Equal [Idea or Concept]
   739   C1690016:% volume [Qualitative Concept]
   739   C1705102:Volume [Intellectual Product]
   739   C1883712:Addition [Functional Concept]
   739   C2700258:Volume [Laboratory Procedure]
   706   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "and"

Phrase: "precipitated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "separated by centrifugation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "at 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "000g for 15 min"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.64: Supernatant was transferred to a new tube and mixed with eight volumes of water. 

Phrase: "Supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "transferred to a new tube"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0175730:Tube [Medical Device]
   760   C0205314:New [Temporal Concept]
   760   C0348011:transferred [Functional Concept]
   760   C1547937:Tube NOS [Intellectual Product]
   760   C1561954:tube [Conceptual Entity]
   760   C1704730:TUBE [Medical Device]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "mixed with eight volumes of water."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0205430:Mixed [Functional Concept]
   753   C0205454:Eight [Quantitative Concept]
   753   C0449468:volumes [Quantitative Concept]
   753   C0599638:WATER [Substance]
   753   C1550678:Water [Inorganic Chemical]
   753   C3160715:Mixed [Finding]
   719 E C1421951:MIX [Gene or Genome]
   719 E C1690016:% volume [Qualitative Concept]
   719 E C1705102:Volume [Intellectual Product]
   719 E C1720722:Mix [Qualitative Concept]
   719 E C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.65: The resulting sample was applied to the preconditioned C18/OH solid-phase extraction column. 

Phrase: "The resulting sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "applied to the preconditioned C18/OH solid-phase extraction column."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   782   C1720880:Solid Phase Extraction [Laboratory Procedure]
   739   C0185115:Extraction [Therapeutic or Preventive Procedure]
   739   C0185125:Applied [Health Care Activity]
   739   C0205208:Solid [Qualitative Concept]
   739   C0205390:Phase [Temporal Concept]
   739   C0220853:OH- [Element, Ion, or Isotope]
   739   C0302909:Solid [Substance]
   739   C0684295:extraction [Laboratory Procedure]
   739   C1185738:Column [Body Part, Organ, or Organ Component]
   739   C1378566:Solid [Biomedical or Dental Material]
   739   C1706132:Column [Idea or Concept]
   706   C0871117:precondition [Mental Process]
   706 E C1632850:Apply [Functional Concept]
   706   C1709632:Precondition [Conceptual Entity]
   706 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.66: The solid-phase extraction column was washed with 5 ml of 50 mmol/l KH2PO4 buffer (pH 7.5), and then retained compounds were eluted with 3 ml of 15% methanol in the same buffer. 

Phrase: "The solid-phase extraction column"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]
   756   C1720880:Solid Phase Extraction [Laboratory Procedure]

Phrase: "was"

Phrase: "washed with 5 ml of 50 mmol/l KH2PO4 buffer"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C1532563:mmol/L [Quantitative Concept]
   757   C0347982:mmol/mL [Quantitative Concept]
   757   C1635169:mL/L [Quantitative Concept]
   757   C2827854:mL/mmol [Quantitative Concept]
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0439190:MMOLE [Quantitative Concept]
   739   C0439526:/mL [Quantitative Concept]
   739   C1548982:Washed [Idea or Concept]
   706 E C0441648:Wash [Activity]

Phrase: "(pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "then retained compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205198:Compound [Qualitative Concept]
   793   C1706082:Compound [Chemical]

Phrase: "were"

Phrase: "eluted with 3 ml of 15% methanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C0439526:/mL [Quantitative Concept]

Phrase: "in the same buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.67: The elute was loaded into the immunoaffinity column prepared with monoclonal antibody for 8-OHG (kindly provided by Dr. Bruce Ames, University of California, Berkeley, CA). 

Phrase: "The"

Phrase: "elute"

Phrase: "was"

Phrase: "loaded into the immunoaffinity column"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C1185738:Column [Body Part, Organ, or Organ Component]
   760   C1706132:Column [Idea or Concept]
   760   C1708715:Loaded [Activity]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]

Phrase: "prepared with monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0746619:monoclonal [Finding]
   737   C1521827:Prepare [Functional Concept]

Phrase: "for 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(kindly"

Phrase: "provided by Dr. Bruce Ames,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0031831:DR [Professional or Occupational Group]
   760   C1332417:BRUCE [Gene or Genome]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C1999230:Provided [Activity]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3540849:DR [Idea or Concept]

Phrase: "University of California,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006754:California [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C3146274:California [Plant]

Phrase: "Berkeley,"

Phrase: "CA)."
Processing 00000000.tx.68: Purified 8-OHG was dissolved in 50 l water and injected into an HPLC device equipped with a Beckman Ultrasphere ODS column (5 m, 4.6 mm x 25 cm) and an electrochemical detector (Coulchem Model 5100 A; ESA). 

Phrase: "Purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "dissolved in 50 l water"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   760   C0599638:WATER [Substance]
   760   C1550678:Water [Inorganic Chemical]
   726   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "injected into an HPLC device"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   833   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   833   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   833   C1579831:High performance liquid chromatography [Functional Concept]
   770   C0008565:Liquid Chromatography [Laboratory Procedure]
   744   C0008550:Chromatography [Laboratory Procedure]
   744   C0025080:Device [Medical Device]
   744   C0205250:High [Qualitative Concept]
   744   C0302908:Liquid [Substance]
   744   C0597198:Performance [Individual Behavior]
   744   C0699733:Device [Manufactured Object]
   744   C1299351:High [Qualitative Concept]
   744   C1304698:Liquid [Finding]
   744   C1546699:Liquid NOS [Intellectual Product]
   744   C1561501:Liquid NOS [Substance]
   744   C1882330:Performance [Activity]
   744   C2700149:HIGH [Intellectual Product]
   711   C1720154:Inject [Functional Concept]

Phrase: "equipped with a Beckman Ultrasphere ODS column"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0611906:ultrasphere-ODS [Organic Chemical]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1706132:Column [Idea or Concept]

Phrase: "(5 m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "4.6 mm x 25 cm)"

Phrase: "and"

Phrase: "an electrochemical detector"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0180392:Detector [Medical Device]
   861   C1705235:Detector [Manufactured Object]

Phrase: "(Coulchem Model 5100 A"

Phrase: "; ESA"

Phrase: ")."
Processing 00000000.tx.69: The height of the 8-OHG peak and the total radioactivity of the elute were measured. 

Phrase: "The height of the 8-OHG peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0489786:Height [Organism Attribute]

Phrase: "and"

Phrase: "the total radioactivity of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "elute"

Phrase: "were"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.70: The height of the peak was used to determine the total amount of 8-OHG injected, which was the sum of the plasma 8-OHG and [14C]-OHG added. 

Phrase: "The height of the peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0489786:Height [Organism Attribute]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the total amount of 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "the sum of the plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515051:Sum [Quantitative Concept]

Phrase: "and ["

Phrase: "14C"

Phrase: "]-OHG"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.71: The amount of 8-OHG was determined by subtracting the amount of [14C]-OHG injected from the total amount of 8-OHG injected. 

Phrase: "The amount of 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "determined by subtracting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1719767:Subtract [Intellectual Product]
   756   C2348589:Subtract [Phenomenon or Process]

Phrase: "the amount of [14C"

Phrase: "]-OHG"

Phrase: "injected from the total amount of 8-OHG"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C1265611:Amount [Quantitative Concept]
   711   C1720154:Inject [Functional Concept]

Phrase: "injected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]
Processing 00000000.tx.72: The amount of [14C]-OHG injected was determined from the calibration curve of the peak height of [14C]-OHG. 

Phrase: "The amount of [14C"

Phrase: "]-OHG"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "was"

Phrase: "determined from the calibration curve of the peak height of [14C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0006751:Calibration [Quantitative Concept]
   738   C0205134:Curve [Spatial Concept]
   738   C0444505:Peak [Quantitative Concept]
   738   C0489786:Height [Organism Attribute]

Phrase: "]-OHG."
Processing 00000000.tx.73: The radioactivity of the elute was used to determine the amount of loss of 8-OHG during the purification procedure using the immunoaffinity column. 

Phrase: "The radioactivity of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "elute"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the amount of loss of 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "during the purification procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the immunoaffinity column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]
Processing 00000000.tx.74: Analysis of data. 

Phrase: "Analysis of data."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0010992:Data Analysis [Occupational Activity]
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
Processing 00000000.tx.75: All data presented were expressed as the mean  SE. 

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "were"

Phrase: "expressed as the mean  SE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0444504:Mean [Quantitative Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.76: Correlations between plasma 8-OHG levels and tissue 8-OHdG levels were analyzed by Spearmans correlation because the distributions of plasma 8-OHG levels and kidney 8-OHdG levels were skewed. 

Phrase: "Correlations between plasma 8-OHG levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "tissue 8-OHdG levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "analyzed by Spearmans correlation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0936012:Analyzed [Research Activity]
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "because"

Phrase: "the distributions of plasma 8-OHG levels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0037775:Distributions [Spatial Concept]
   714 E C0520511:distribution [Idea or Concept]
   714 E C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "kidney 8-OHdG levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "skewed."
Processing 00000000.tx.77: The levels of 8-OHG or 8-OHdG between groups were compared by analysis of variance with the post hoc least significance difference test. 

Phrase: "The levels of 8-OHG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "8-OHdG between groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "compared by analysis of variance"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1707455:Compared [Activity]
   760   C1711260:Variance [Qualitative Concept]
   760   C2348152:Variance [Quantitative Concept]

Phrase: "with the post hoc least significance difference test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0022885:Test [Laboratory Procedure]
   799   C0039593:Test [Functional Concept]
   799   C0392366:test [Intellectual Product]
Processing 00000000.tx.78: P < 0.05 was considered to be significant.  

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "significant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.79: RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Metabolic characteristics of the animals. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Metabolic characteristics of the animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristics [Qualitative Concept]
Processing 00000000.tx.80: Blood glucose levels in DR were about five times higher than those in CR at 4 weeks postSTZ treatment (DR 26.9  0.6 mmol/l vs. CR 4.7  0.2 mmol/l; P < 0.005) (Table 1). 

Phrase: "Blood glucose levels in DR"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   833   C0428554:blood glucose levels [Laboratory or Test Result]
   790   C0005802:Blood Glucose [Carbohydrate]
   790   C0428548:glucose levels [Laboratory or Test Result]
   756 E C0337438:glucose level [Laboratory Procedure]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0229664:Blood [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "about five times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "higher than those"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "in CR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "at 4 weeks postSTZ treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "(DR 26.9  0.6 mmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1532563:mmol/L [Quantitative Concept]

Phrase: "vs. CR 4.7  0.2 mmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1532563:mmol/L [Quantitative Concept]

Phrase: "; P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.81: DR had significantly higher 24-h urine volume and lower body weight compared with CR (24 h urine volume: 120.4  20.1 vs. 

Phrase: "DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "had"

Phrase: "significantly higher 24-h urine volume"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0232856:Urine volume [Clinical Attribute]
   827   C1278293:Urine volume [Laboratory Procedure]
   827   C1287298:Urine volume [Finding]
   799   C0042036:Urine [Body Substance]
   799   C0042037:urine [Functional Concept]
   799   C0449468:*Volume [Quantitative Concept]
   799   C1690016:% volume [Qualitative Concept]
   799   C1705102:Volume [Intellectual Product]
   799   C2700258:Volume [Laboratory Procedure]
   799   C2963137:Urine [Body Substance]

Phrase: "and"

Phrase: "lower body weight"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   901   C0005910:Body Weight [Organism Attribute]
           weight
   901   C1268088:Lower body [Body Part, Organ, or Organ Component]
   901   C1305866:body weight [Diagnostic Procedure]
           weight
   827   C0043100:Weight [Quantitative Concept]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   827   C1705104:Weight [Idea or Concept]
   743 E C1995017:Bodies [Cell Component]

Phrase: "compared with CR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(24 h urine volume"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0232856:Urine volume [Clinical Attribute]
   861   C1278293:Urine volume [Laboratory Procedure]
   861   C1287298:Urine volume [Finding]
   812   C0042036:Urine [Body Substance]
   812   C0042037:urine [Functional Concept]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]
   812   C2963137:Urine [Body Substance]

Phrase: ":"

Phrase: "120.4  20.1"

Phrase: "vs."
Processing 00000000.tx.82: 19.1  0.8 ml for DR vs. 

Phrase: "19.1  0.8 ml for DR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439526:/mL [Quantitative Concept]

Phrase: "vs."
Processing 00000000.tx.83: CR, P < 0.005; 

Phrase: "CR,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.84: body weight: 237.1  18.3 vs. 

Phrase: "body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: ":"

Phrase: "237.1  18.3"

Phrase: "vs."
Processing 00000000.tx.85: 346.3  9.3 g for DR vs. 

Phrase: "346.3  9.3 g for DR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439267:g% [Quantitative Concept]

Phrase: "vs."
Processing 00000000.tx.86: CR, P < 0.005) (Table 1). 

Phrase: "CR,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.87: Insulin treatment attenuated the hyperglycemia, weight loss, and polyuria seen in DR, although they were not completely reversed to the levels of CR by insulin treatment (blood glucose: 26.9  0.6 vs. 

Phrase: "Insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "the hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "weight loss,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0043096:WEIGHTLOSS [Finding]
  1000   C2911645:Weight loss [Finding]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1517945:Loss [Quantitative Concept]
   861   C1705104:Weight [Idea or Concept]

Phrase: "and"

Phrase: "polyuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032617:Polyuria [Sign or Symptom]

Phrase: "seen in DR,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0205397:Seen [Qualitative Concept]
   770   C0241863:DIABETIC [Finding]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "although"

Phrase: "they"

Phrase: "were"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "reversed to the levels of CR"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0243148:control [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714   C1555029:Reverse [Idea or Concept]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "by insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "26.9  0.6"

Phrase: "vs."
Processing 00000000.tx.88: 14.3  1.3 mmol/l for DR vs. 

Phrase: "14.3  1.3 mmol/l for DR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   764   C1532563:mmol/L [Quantitative Concept]

Phrase: "vs."
Processing 00000000.tx.89: DR+I; 

Phrase: "DR+I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.90: P < 0.005) (Table 1). 

Phrase: "P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: There was no significant difference in body weight, 24-h urine volume, blood glucose level, and injected insulin dose between DR+I and DR+I/P or between DR+I and D+I/E (Table 1). 

Phrase: "There"

Phrase: "was"

Phrase: "no significant difference in body weight,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "24-h urine volume,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0232856:Urine volume [Clinical Attribute]
   861   C1278293:Urine volume [Laboratory Procedure]
   861   C1287298:Urine volume [Finding]
   812   C0042036:Urine [Body Substance]
   812   C0042037:urine [Functional Concept]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]
   812   C2963137:Urine [Body Substance]

Phrase: "blood glucose level,"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0428554:Blood glucose level [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0337438:glucose level [Laboratory Procedure]
   901   C0428548:Glucose level [Laboratory or Test Result]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "injected insulin dose between DR+I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C2986768:Injected Dose [Functional Concept]
   748   C0178602:Dose [Quantitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "DR+I/P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or between DR+I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0021966:I- [Inorganic Chemical]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "D+"

Phrase: "I/E (Table 1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   902   C0963236:I-1 [Amino Acid, Peptide, or Protein,Receptor]
   902   C1425233:I-1 [Gene or Genome]
   902   C3540559:I-1 [Gene or Genome]
   861   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   812   C0021966:I- [Inorganic Chemical]
   812   C0039224:Table [Manufactured Object]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C1706073:Table [Medical Device]
   812   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.92: View this table: [in this window] [in a new window]  TABLE 1 Clinical characteristics of STZ-induced DR, DR+I, DR+I/P, or DR+I/E  Correlation between plasma 8-OHG levels and tissue 8-OHdG levels. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Clinical characteristics of STZ-induced DR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0683325:clinical characteristics [Clinical Attribute]
   742   C1521970:Characteristics [Qualitative Concept]

Phrase: "DR+I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "DR+I/P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "DR+I/E  Correlation between plasma 8-OHG levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "tissue 8-OHdG levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.93: There was a correlation between plasma 8-OHG levels and tissue 8-OHdG levels (plasma 8-OHG vs. liver 8-OHdG: r = 0.64, P < 0.001; 

Phrase: "There"

Phrase: "was"

Phrase: "a correlation between plasma 8-OHG levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "tissue 8-OHdG levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "vs. liver 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "r = 0.64,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.94: plasma 8-OHG vs. kidney 8-OHdG: r = 0.38, P = 0.06) (Figs. 1A and B). 

Phrase: "plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "vs. kidney 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "r = 0.38,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P = 0.06"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Figs. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.95: Liver 8-OHdG levels also correlated with kidney 8-OHdG levels (r = 0.435; P = 0.038) (Fig. 1C). 

Phrase: "Liver 8-OHdG levels also"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "correlated with kidney 8-OHdG levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0022646:Kidney [Body Part, Organ, or Organ Component]
   753   C0227665:kidney [Body Part, Organ, or Organ Component]
   753   C0441889:Levels [Qualitative Concept]
   753   C1278978:Kidney [Body Part, Organ, or Organ Component]
   753   C1514845:KIDNEY [Tissue]
   753   C1707520:Correlated [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(r = 0.435"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "; P = 0.038"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.96: View larger version (13K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.97: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.98: Correlations between plasma 8-OHG and liver 8-OHdG (A), plasma 8-OHG and kidney 8-OHdG (B), and liver 8-OHdG and kidney 8-OHdG (C). 

Phrase: "Correlations between plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "liver 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "kidney 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "liver 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "kidney 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.99: The levels of plasma 8-OHG and tissue 8-OHdG were measured by HPLC-ECD.  

Phrase: "The levels of plasma 8-OHG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "tissue 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "measured by HPLC-ECD."
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   853   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   853   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   853   C1579831:High performance liquid chromatography [Functional Concept]
   778   C0008565:Liquid Chromatography [Laboratory Procedure]
   748   C0008550:Chromatography [Laboratory Procedure]
   748   C0205250:High [Qualitative Concept]
   748   C0302908:Liquid [Substance]
   748   C0444706:Measured [Qualitative Concept]
   748   C0597198:Performance [Individual Behavior]
   748   C1299351:High [Qualitative Concept]
   748   C1304698:Liquid [Finding]
   748   C1546699:Liquid NOS [Intellectual Product]
   748   C1561501:Liquid NOS [Substance]
   748   C1882330:Performance [Activity]
   748   C2700149:HIGH [Intellectual Product]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.100: Plasma 8-OHG levels in DR treated with insulin and antioxidant. 

Phrase: "Plasma 8-OHG levels in DR"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "antioxidant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]
Processing 00000000.tx.101: Plasma 8-OHG levels in DR were significantly higher than those in CR (10.4  2.2 vs. 3.3  1.2 pmol/ml for DR vs. CR; P < 0.05) (Fig. 2). 

Phrase: "Plasma 8-OHG levels in DR"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly higher than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in CR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(10.4  2.2"

Phrase: "vs. 3.3  1.2 pmol/ml for DR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439282:pmol/mL [Quantitative Concept]
   739   C0439526:/mL [Quantitative Concept]

Phrase: "vs. CR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "; P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.102: Insulin treatment normalized elevated levels of plasma 8-OHG in DR (plasma 8-OHG: 10.4  2.3 vs. 

Phrase: "Insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "elevated levels of plasma 8-OHG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "(plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "10.4  2.3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C1883310:10^3 [Quantitative Concept]

Phrase: "vs."
Processing 00000000.tx.103: 3.6  1.0 pmol/ml for DR vs. 

Phrase: "3.6  1.0 pmol/ml for DR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0439282:pmol/mL [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]

Phrase: "vs."
Processing 00000000.tx.104: DR+I; 

Phrase: "DR+I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.105: P < 0.05) (Fig. 2). 

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.106: Adding probucol or vitamin E to the insulin treatment tended to further decrease plasma 8-OHG levels, although it did not reach significance (3.6  1.0, 2.8  1.0, and 1.8  1.9 pmol/ml for DR+I, DR+I/P, and DR+I/E, respectively; P = NS for DR+I vs. both DR+I/P and DR+I/E) (Fig. 2). 

Phrase: "Adding probucol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033215:Probucol [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "vitamin E to the insulin treatment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   753   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   734 E C0591450:Ephynal [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "tended"

Phrase: "to further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "plasma 8-OHG levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "although"

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "(3.6  1.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442759:3 6 [Finding]
   812   C0439086:<3 [Quantitative Concept]
   812   C2827736:3+ [Quantitative Concept]
   812   C2981702:3+ [Classification]

Phrase: "2.8  1.0,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "1.8  1.9 pmol/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439282:pmol/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "for DR+I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "DR+I/P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "DR+I/E, respectively"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   804   C0021966:I- [Inorganic Chemical]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0241863:DIABETIC [Finding]

Phrase: "; P = NS for DR+I"

Phrase: "vs."

Phrase: "both DR+I/P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "DR+I/E) (Fig. 2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   799   C0021966:I- [Inorganic Chemical]
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0241863:DIABETIC [Finding]
   799   C0349966:Fig [Food]
   799   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.107: View larger version (16K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.108: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.109: Effects of insulin and antioxidant treatment on plasma 8-OHG levels in STZ-induced DR. 

Phrase: "Effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "antioxidant treatment on plasma 8-OHG levels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "in STZ-induced DR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]
Processing 00000000.tx.110: DR+I: target blood glucose 200300 mg/dl. 

Phrase: "DR+I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "target blood glucose 200300 mg/dl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439269:mg dl [Quantitative Concept]
   799   C3642216:/dL [Quantitative Concept]
Processing 00000000.tx.111: DR + I/P: insulin and probucol were administered at 1% of food weight. 

Phrase: "DR + I/P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "probucol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033215:Probucol [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "at 1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "of food weight."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1705104:Weight [Idea or Concept]
Processing 00000000.tx.112: DR + I/E: insulin and vitamin E were administered at 100 IU/kg food wt. 

Phrase: "DR + I/E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "vitamin E"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   944 E C0591450:Ephynal [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "were"

Phrase: "administered at 100 IU/kg food wt."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0439463:IU/kg [Quantitative Concept]
   748   C0016452:Food [Food]
   748   C0022718:KG [Geographic Area]
   748   C0439209:kg [Quantitative Concept]
   748   C0439453:IU [Quantitative Concept]
   748   C1521801:Administered [Functional Concept]
   748   C2700323:WT [Fish]
   714 E C1621583:Administer [Functional Concept]
Processing 00000000.tx.113: Rats were treated for 4 weeks until killed. 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "treated for 4 weeks"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0439230:weeks [Temporal Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C0332174:/week [Temporal Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "until"

Phrase: "killed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]
Processing 00000000.tx.114: Plasma 8-OHG levels were significantly increased in DR. 

Phrase: "Plasma 8-OHG levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "increased in DR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0205217:Increased [Quantitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0442805:Increased [Functional Concept]
Processing 00000000.tx.115: Insulin treatment completely reversed elevated levels of plasma 8-OHG in DR. 

Phrase: "Insulin treatment completely"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "reversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555029:Reverse [Idea or Concept]

Phrase: "elevated levels of plasma 8-OHG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in DR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.116: The addition of probucol and vitamin E to insulin tended to decrease plasma 8-OHG.  

Phrase: "The addition of probucol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "and"

Phrase: "vitamin E to insulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   777 E C0591450:Ephynal [Organic Chemical,Pharmacologic Substance,Vitamin]
   770   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "plasma 8-OHG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.117: Tissue 8-OHdG levels in DR treated with insulin and antioxidant. 

Phrase: "Tissue 8-OHdG levels in DR"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "antioxidant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]
Processing 00000000.tx.118: In DR, liver 8-OHdG levels were significantly higher than those in CR (8-OHdG/105 dG: 0.38  0.04 vs. 

Phrase: "In DR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "liver 8-OHdG levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly higher than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in CR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(8-OHdG/105 dG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "0.38  0.04"

Phrase: "vs."
Processing 00000000.tx.119: 0.21  0.03 for DR vs. 

Phrase: "0.21  0.03 for DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0241863:DIABETIC [Finding]

Phrase: "vs."
Processing 00000000.tx.120: CR; 

Phrase: "CR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.121: P < 0.005) (Fig. 3A). 

Phrase: "P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.122: Likewise, kidney 8-OHdG levels in DR were significantly higher than those in CR (8-OHdG/105 dG: 1.22  0.19 vs. 

Phrase: "Likewise,"

Phrase: "kidney 8-OHdG levels in DR"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly higher than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in CR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(8-OHdG/105 dG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "1.22  0.19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "vs."
Processing 00000000.tx.123: 0.70  0.02 for DR vs. 

Phrase: "0.70  0.02 for DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0241863:DIABETIC [Finding]

Phrase: "vs."
Processing 00000000.tx.124: CR; 

Phrase: "CR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.125: P < 0.05) (Fig. 3B). 

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.126: In contrast with 8-OHG, 8-OHdG in liver and kidney was not significantly decreased by insulin treatment (liver 8-OHdG/105 dG: 0.39  0.04 vs. 

Phrase: "In contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "with 8-OHG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "8-OHdG in liver"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "was"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "decreased by insulin treatment"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0547047:Decrease [Quantitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(liver 8-OHdG/105 dG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "0.39  0.04"

Phrase: "vs."
Processing 00000000.tx.127: 0.31  0.04 for DR vs. 

Phrase: "0.31  0.04 for DR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0241863:DIABETIC [Finding]
   748   C0450355:31 [Intellectual Product]

Phrase: "vs."
Processing 00000000.tx.128: DR+I, P = 0.19; 

Phrase: "DR+I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "P = 0.19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.129: kidney 8-OHdG/105dG: 1.21  0.01 vs. 

Phrase: "kidney 8-OHdG/105dG"

Phrase: ":"

Phrase: "1.21  0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "vs."
Processing 00000000.tx.130: 0.92  0.15 for DR vs. 

Phrase: "0.92  0.15 for DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0241863:DIABETIC [Finding]

Phrase: "vs."
Processing 00000000.tx.131: DR+I, P = 0.08) (Figs. 3A and B). 

Phrase: "DR+I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "P = 0.08"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Figs. 3A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.132: However, a combined treatment of insulin and probucol normalized tissue 8-OHdG levels (liver 8-OHdG/105 dG: 0.38  0.04 vs. 

Phrase: "However,"

Phrase: "a combined treatment of insulin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0009429:combined treatment [Therapeutic or Preventive Procedure]
   806   C1704537:Combined Treatment [Therapeutic or Preventive Procedure]
   797   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "probucol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033215:Probucol [Organic Chemical,Pharmacologic Substance]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "tissue 8-OHdG levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(liver 8-OHdG/105 dG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "0.38  0.04"

Phrase: "vs."
Processing 00000000.tx.133: 0.15  0.02 for DR vs. 

Phrase: "0.15  0.02 for DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0241863:DIABETIC [Finding]

Phrase: "vs."
Processing 00000000.tx.134: DR+I/P, P < 0.005; 

Phrase: "DR+I/P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.135: kidney 8-OHdG/105 dG: 1.22  0.19 vs. 

Phrase: "kidney 8-OHdG/105 dG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "1.22  0.19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "vs."
Processing 00000000.tx.136: 0.73  0.05 for DR vs. 

Phrase: "0.73  0.05 for DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0241863:DIABETIC [Finding]

Phrase: "vs."
Processing 00000000.tx.137: DR+I/P, P = 0.007) (Figs. 3A and B). 

Phrase: "DR+I/P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "P = 0.007"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Figs. 3A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.138: Similarly, insulin and vitamin E treatment (I/E) significantly decreased tissue 8-OHdG levels (liver 8-OHdG/105dG: 0.38  0.04 vs. 

Phrase: "Similarly,"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "vitamin E treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]

Phrase: "(I/E) significantly decreased tissue 8-OHdG levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   892   C0441925:i levels [Intellectual Product]
   793   C0441889:Levels [Qualitative Concept]
   760 E C0456079:Level [Classification]
   760 E C1547707:Level [Geographic Area]
   760 E C2946261:Level [Pharmacologic Substance]

Phrase: "(liver 8-OHdG/105dG"

Phrase: ":"

Phrase: "0.38  0.04"

Phrase: "vs."
Processing 00000000.tx.139: 0.22  0.03 for DR vs. 

Phrase: "0.22  0.03 for DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0241863:DIABETIC [Finding]

Phrase: "vs."
Processing 00000000.tx.140: DR+I/E, P = 0.004; 

Phrase: "DR+I/E, P = 0.004"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   795   C0021966:I- [Inorganic Chemical]
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]
   795   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0241863:DIABETIC [Finding]

Phrase: ";"
Processing 00000000.tx.141: kidney 8-OHdG/105 dG: 1.22  0.19 vs. 

Phrase: "kidney 8-OHdG/105 dG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "1.22  0.19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "vs."
Processing 00000000.tx.142: 0.61  0.04 for DR vs. 

Phrase: "0.61  0.04 for DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0241863:DIABETIC [Finding]

Phrase: "vs."
Processing 00000000.tx.143: DR+I/E, P = 0.004) (Figs. 3A and B). 

Phrase: "DR+I/E, P = 0.004"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   795   C0021966:I- [Inorganic Chemical]
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]
   795   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0241863:DIABETIC [Finding]

Phrase: ")"

Phrase: "(Figs. 3A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.144: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.145: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.146: Effects of insulin and antioxidant treatment on liver 8-OHdG (A) and kidney 8-OHdG (B) in DR. 

Phrase: "Effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "antioxidant treatment on liver 8-OHdG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "(A)"

Phrase: "and"

Phrase: "kidney 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(B) in DR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.147: Compared with CR, DR had higher levels of liver and kidney 8-OHdG. 

Phrase: "Compared with CR,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "had"

Phrase: "higher levels of liver"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "kidney 8-OHdG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.148: Insulin treatment did not significantly decrease liver and kidney 8-OHdG levels, but combined treatment of insulin and antioxidant normalized liver and kidney 8-OHdG levels.  

Phrase: "Insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "kidney 8-OHdG levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "combined treatment of insulin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0009429:combined treatment [Therapeutic or Preventive Procedure]
   833   C1704537:Combined Treatment [Therapeutic or Preventive Procedure]
   819   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "antioxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "kidney 8-OHdG levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.149: Correlation between blood glucose levels and plasma 8-OHG or tissue 8-OHdG levels. 

Phrase: "Correlation between blood glucose levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "tissue 8-OHdG levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.150: Neither 8-OHG levels nor 8-OHdG levels were significantly correlated with mean blood glucose levels during insulin treatment, although kidney 8-OHdG levels showed an increasing tendency along with blood glucose levels (r = 0.32; P = 0.07).  

Phrase: "Neither 8-OHG levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "nor"

Phrase: "8-OHdG levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "significantly"

Phrase: "correlated with mean blood glucose levels"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   833   C0428554:blood glucose levels [Laboratory or Test Result]
   790   C0005802:Blood Glucose [Carbohydrate]
   790   C0428548:glucose levels [Laboratory or Test Result]
   756 E C0337438:glucose level [Laboratory Procedure]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0229664:Blood [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C0444504:Mean [Quantitative Concept]
   753   C1707520:Correlated [Qualitative Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "during insulin treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "although"

Phrase: "kidney 8-OHdG levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an increasing tendency along with blood glucose levels"

Phrase: "(r = 0.32"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "; P = 0.07"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.151: DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  In the diabetic state, increased ROS production and decreased antioxidant capacity has been observed, both resulting in increased oxidative stress (1,2,3). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  In the diabetic state,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0241863:DIABETIC [Finding]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]
   760   C3148680:State [Geographic Area]

Phrase: "increased ROS production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "decreased antioxidant capacity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003402:Antioxidant [Pharmacologic Substance]
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "both"

Phrase: "resulting in increased oxidative stress"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   806   C0332294:Resulting in [Functional Concept]
   797   C0231298:Increased stress [Functional Concept]
   760   C0038435:Stress [Finding]
   760   C0205217:Increased [Quantitative Concept]
   760   C0311404:Oxidative [Functional Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0678226:resulting [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.152: Enhanced oxidative stress may be closely related to pathogenesis of diabetic macro- and microangiopathy by exerting direct oxidative damage and also by activating the pathways implicated in diabetic angiopathy (3,4). 

Phrase: "Enhanced oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "closely"

Phrase: "related to pathogenesis of diabetic macro-"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0241863:DIABETIC [Finding]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]
   753   C2984010:Macro [Conceptual Entity]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "microangiopathy by exerting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0155765:Microangiopathy [Disease or Syndrome]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "also by activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1879547:activating [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "the pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "implicated in diabetic angiopathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0011875:Diabetic angiopathy [Disease or Syndrome]
   770   C0042373:Angiopathy [Disease or Syndrome]
   770   C0241863:DIABETIC [Finding]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.153: 8-OHdG is produced by oxidative modification of both the purine base in DNA and the repairing process (10,11,12). 

Phrase: "8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "produced by oxidative modification of both"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0311404:Oxidative [Functional Concept]
   753   C0392747:Modification [Functional Concept]
   753   C1554963:modification [Qualitative Concept]

Phrase: "the purine base in DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002055:base [Inorganic Chemical]
   760   C0178499:Base [Chemical Viewed Functionally]
   760   C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "the repairing process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "(10,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.154: The levels of 8-OHdG in urine and tissue are increased in many conditions complicated with enhanced oxidative damage, such as cancer, aging, radiation injury, and smoking (22,23). 

Phrase: "The levels of 8-OHdG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in urine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]

Phrase: "and"

Phrase: "tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "are"

Phrase: "increased in many conditions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "complicated with enhanced oxidative damage,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0010957:Damage [Injury or Poisoning]
   760   C0231242:Complicated [Functional Concept]
   760   C0311404:Oxidative [Functional Concept]
   760   C1883709:Damage [Functional Concept]
   760   C2349975:Enhanced [Activity]

Phrase: "such as cancer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: ","

Phrase: "radiation injury,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034530:Radiation injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "and"

Phrase: "smoking"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037369:Smoking [Individual Behavior]
  1000   C0453996:Smoking [Individual Behavior]
  1000   C1881674:SMOKING [Phenomenon or Process]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.155: Although urinary excretion of 8-OHdG has been commonly used as a biomarker for systemic oxidative stress, 8-OHdG assay has been limited by low sensitivity because of auto-oxidation of dG during the sample preparation and work-up procedure (7,8,9,17). 

Phrase: "Although"

Phrase: "urinary excretion of 8-OHdG"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0042027:Urinary [Body Part, Organ, or Organ Component]
   760   C0221102:Excretion [Physiologic Function]
   760   C0504085:Excretion [Body Substance]
   760   C1524119:urinary [Qualitative Concept]
   760   C2699704:EXCRETION [Regulation or Law]

Phrase: "has"

Phrase: "been"

Phrase: "commonly"

Phrase: "used as a biomarker"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0005516:Biomarker [Clinical Attribute]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "for systemic oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "8-OHdG assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "has"

Phrase: "been"

Phrase: "limited by low sensitivity"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0205251:low [Qualitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C0439801:Limited [Functional Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]
   770   C3542948:Limited [Intellectual Product]
   737 E C1549649:Limit [Idea or Concept]
   737 E C2349209:Limit [Conceptual Entity]

Phrase: "because of auto-oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   861   C0030011:Oxidation [Molecular Function]
   861   C1441488:Auto [Laboratory Procedure]

Phrase: "of dG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "during the sample preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "work-up procedure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]
   734   C0750430:Work-up [Diagnostic Procedure]

Phrase: "(7,"

Phrase: "8,"

Phrase: "9,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.156: In this study, we measured plasma 8-OHG along with tissue 8-OHdG because 8-OHG is more stable due to resistance to auto-oxidation (18). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "plasma 8-OHG along with tissue 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "because"

Phrase: "8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "more stable due to resistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205360:Stable [Qualitative Concept]
   760   C1547311:Stable [Intellectual Product]

Phrase: "to auto-oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   861   C0030011:Oxidation [Molecular Function]
   861   C1441488:Auto [Laboratory Procedure]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.157: We found that the plasma 8-OHG level significantly correlated with the tissue 8-OHdG level. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the plasma 8-OHG level significantly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0441889:Level [Qualitative Concept]
   804   C0456079:Level [Classification]
   804   C1547707:Level [Geographic Area]
   804   C2946261:Level [Pharmacologic Substance]

Phrase: "correlated with the tissue 8-OHdG level."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0040300:Tissue [Tissue]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C1547928:Tissue [Intellectual Product]
   748   C1707520:Correlated [Qualitative Concept]
   748   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.158: Thus, it could be concluded that plasma 8-OHG is a good indicator for oxidative DNA damage in tissue. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "a good indicator for oxidative DNA damage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   748   C1235732:Indicator [Bird]
   748   C1522602:Indicator [Functional Concept]

Phrase: "in tissue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.159: Dandona et al. 

Phrase: "Dandona et al."
Processing 00000000.tx.160: (13) have demonstrated that diabetic patients have higher levels of 8-OHdG in mononuclear cells. 

Phrase: "(13"

Phrase: ")"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "higher levels of 8-OHdG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in mononuclear cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0806987:Mononuclear cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1513475:Mononuclear [Clinical Attribute]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.161: An increase in the urinary excretion of 8-OHdG has also been seen in diabetic patients (13,14,15). 

Phrase: "An increase in the urinary excretion of 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "seen in diabetic patients"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205397:Seen [Qualitative Concept]
   770   C0241863:DIABETIC [Finding]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "(13,"

Phrase: "14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.162: We have recently demonstrated that plasma 8-OHG levels are increased in diabetic patients, especially those with advanced diabetic microvascular complications (24). 

Phrase: "We"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrated"

Phrase: "that plasma 8-OHG levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased in diabetic patients,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205217:Increased [Quantitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0442805:Increased [Functional Concept]

Phrase: "especially"

Phrase: "those with advanced diabetic microvascular complications"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   783   C0342257:Diabetic Complications [Pathologic Function]
   753   C0009566:Complications [Pathologic Function]
   753   C0205179:Advanced [Qualitative Concept]
   753   C0241863:DIABETIC [Finding]
   753   C0443258:Microvascular [Functional Concept]
   753   C1171258:complications [Pathologic Function]
   719 E C2362589:Complication [Idea or Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.163: In agreement with previous observations, DR had significantly higher levels of 8-OHdG and 8-OHG compared with normal CR in the present study. 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with previous observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "had"

Phrase: "significantly higher levels of 8-OHdG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "compared with normal CR"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C2705716:normal control [Qualitative Concept]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205307:Normal [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2347086:% Normal [Quantitative Concept]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "in the present study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.164: Notably, a greater increase was seen in plasma 8-OHG than in liver and kidney 8-OHdG in untreated DR. 

Phrase: "Notably,"

Phrase: "a greater increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "seen in plasma 8-OHG"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0032105:Plasma [Body Substance]
   760   C0205397:Seen [Qualitative Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "than"

Phrase: "in liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "kidney 8-OHdG in untreated DR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.165: Animals in the DR group had about three times higher levels of plasma 8-OHG, whereas the tissue 8-OHdG levels were elevated by 1.5- to 2-fold in untreated DR compared with CR. 

Phrase: "Animals in the DR group"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1642385:Animal group [Group]
   753   C0003062:Animals [Animal]

Phrase: "had"

Phrase: "about three times higher levels of plasma 8-OHG,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "whereas"

Phrase: "the tissue 8-OHdG levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "elevated by 1.5-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205250:Elevated [Qualitative Concept]
   770   C3163633:Elevated [Qualitative Concept]

Phrase: "to 2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "in untreated DR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "compared with CR."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.166: This finding suggests that plasma 8-OHG is a more sensitive marker for oxidative DNA damage. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "a more sensitive marker for oxidative DNA damage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0012872:Marker, DNA [Nucleotide Sequence]
   744   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.167: In the diabetic state, there may be a number of reasons for increased oxidative DNA damage. 

Phrase: "In the diabetic state,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0241863:DIABETIC [Finding]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "there"

Phrase: "may"

Phrase: "be"

Phrase: "a number of reasons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "for increased oxidative DNA damage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   812   C0010957:Damage [Injury or Poisoning]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1883709:Damage [Functional Concept]
Processing 00000000.tx.168: Hyperglycemia itself contributes to increased generation of ROS by producing reactive ketoimine and ketoamine adducts during oxidative glycosylation and glycoxidation, which further produce ROS such as hydrogen peroxide and superoxide anion in the presence of metal ions (3). 

Phrase: "Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "itself"

Phrase: "contributes to increased generation of ROS"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   782   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   739   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C0035820:Role [Social Behavior]
   739   C0079411:Generation [Temporal Concept]
   739   C0205217:Increased [Quantitative Concept]
   739   C0205332:Reactive [Qualitative Concept]
   739   C0442805:Increased [Functional Concept]
   739   C1705810:Role [Conceptual Entity]
   739   C1705920:Species [Conceptual Entity]
   739   C1880177:Contribute [Activity]
   739   C3146294:Generation [Activity]

Phrase: "by producing reactive ketoimine"

Phrase: "and"

Phrase: "ketoamine adducts during oxidative glycosylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596040:adducts [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "glycoxidation,"

Phrase: "which further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "produce"

Phrase: "ROS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "such as hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "and"

Phrase: "superoxide anion in the presence of metal ions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   744   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.169: Thus, reduction of hyperglycemia may be helpful in decreasing oxidative stress. 

Phrase: "Thus,"

Phrase: "reduction of hyperglycemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0301630:Reduction [Natural Phenomenon or Process]
   790   C0392756:Reduction [Qualitative Concept]
   790   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "helpful in decreasing oxidative stress."
Processing 00000000.tx.170: Interestingly, in this study, insulin treatment almost normalized plasma 8-OHG when hyperglycemia was partially corrected by insulin treatment. 

Phrase: "Interestingly,"

Phrase: "in this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "insulin treatment almost normalized plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   818   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "when"

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "was"

Phrase: "partially"

Phrase: "corrected by insulin treatment."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205202:Corrected [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C2349182:Correct [Qualitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.171: However, insulin treatment did not significantly decrease tissue 8-OHdG, although a decreasing tendency in tissue 8-OHdG was seen in insulin-treated DR. 

Phrase: "However,"

Phrase: "insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "tissue 8-OHdG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "although"

Phrase: "a decreasing tendency in tissue 8-OHdG"

Phrase: "was"

Phrase: "seen in insulin-treated DR."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   783   C0421248:diabetic insulin [Finding]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0205397:Seen [Qualitative Concept]
   753   C0241863:DIABETIC [Finding]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C1522326:Treated [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719 E C0042789:see [Organism Function]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1947903:See [Activity]
Processing 00000000.tx.172: This may suggest that normalization of plasma 8-OHG does not mean normalization of oxidative DNA damage in tissue. 

Phrase: "This"

Phrase: "may"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that normalization of plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1882115:Normalization [Research Activity]

Phrase: "does"

Phrase: "not mean normalization of oxidative DNA damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1882115:Normalization [Research Activity]

Phrase: "in tissue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.173: The reason for the discrepancy in the response to insulin treatment between plasma 8-OHG and tissue 8-OHdG is presently unknown. 

Phrase: "The reason for the discrepancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392360:Reason [Idea or Concept]

Phrase: "in the response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "between plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "tissue 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "presently unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.174: Insulin might affect the DNA repairing process or conversion of 8-OHdG to 8-OHG independently of the glucose-lowering effect. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "might"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the DNA repairing process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
   717   C0012899:DNA Repair [Genetic Function]

Phrase: "or"

Phrase: "conversion of 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439836:Conversion [Functional Concept]

Phrase: "to 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "independently of the glucose-lowering effect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1158774:glucose effect [Genetic Function]
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.175: Further investigation will be needed to explain this phenomenon. 

Phrase: "Further investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "will"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explain"

Phrase: "this phenomenon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882365:Phenomenon [Phenomenon or Process]
Processing 00000000.tx.176: Large-scale epidemiological studies have demonstrated that probucol or dietary supplement of vitamin E reduces the risk of coronary artery disease and restenosis after balloon angioplasty (25,26,27). 

Phrase: "Large-scale epidemiological studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0002783:Epidemiological Studies [Research Activity]
   812   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]
   741 E C0014508:epidemiology [Functional Concept]
   741 E C0699910:epidemiology [Health Care Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that probucol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033215:Probucol [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "dietary supplement of vitamin E"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   844   C3661607:Vitamin E supplement [Food]
   806   C0242295:Dietary Supplement [Food]
           Supplement
   806   C2828069:DIETARY SUPPLEMENT [Intellectual Product]
   797   C0681579:Vitamin supplement [Food]
   760   C1947943:Supplement [Intellectual Product]
   760   C2348609:Supplement [Functional Concept]

Phrase: "reduces"

Phrase: "the risk of coronary artery disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   864   C3640263:Coronary Artery Disease Risk [Intellectual Product]
   783   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "restenosis after balloon angioplasty"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333186:Restenosis [Acquired Abnormality]

Phrase: "(25,"

Phrase: "26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.177: In the present study, antioxidant (probucol and vitamin E) treatment, in addition to insulin, normalized elevated tissue 8-OHdG levels. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "antioxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "(probucol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033215:Probucol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "vitamin E"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   944 E C0591450:Ephynal [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: ")"

Phrase: "treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "in addition to insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "elevated tissue 8-OHdG levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.178: This study supports an important role of antioxidant treatment in the reduction of oxidative stress for the prevention of diabetic vascular complications. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "an important role of antioxidant treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "for the prevention"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199176:Prevention [Therapeutic or Preventive Procedure]
  1000   C1706420:PREVENTION [Research Activity]
  1000   C2700409:prevention [Qualitative Concept]

Phrase: "of diabetic vascular complications."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0011875:Diabetic Vascular Complications [Disease or Syndrome]
   913   C0342257:Diabetic Complications [Pathologic Function]
   827   C0009566:Complications [Pathologic Function]
   827   C1171258:complications [Pathologic Function]
   793 E C2362589:Complication [Idea or Concept]
   743 E C0231242:Complicated [Functional Concept]
Processing 00000000.tx.179: Vitamin E, which chelates reactive metal ions, reduces liver and kidney 8-OHdG to a similar degree, whereas probucol is more effective in decreasing liver 8-OHdG. 

Phrase: "Vitamin E,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   944 E C0591450:Ephynal [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "which"

Phrase: "chelates"

Phrase: "reactive metal ions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0022023:Ions [Element, Ion, or Isotope]
   793 E C1700702:ION [Functional Concept]

Phrase: "reduces"

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "kidney 8-OHdG to a similar degree,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "whereas"

Phrase: "probucol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033215:Probucol [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "more effective in decreasing liver 8-OHdG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280519:effective [Qualitative Concept]
   748   C1704419:Effective [Qualitative Concept]
Processing 00000000.tx.180: Correction of hyperlipidemia by probucol, in addition to its antioxidant effect, may contribute to reduction of oxidative damage, especially in liver. 

Phrase: "Correction of hyperlipidemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1705565:CORRECTION [Intellectual Product]
   790   C1947976:Correction [Functional Concept]

Phrase: "by probucol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033215:Probucol [Organic Chemical,Pharmacologic Substance]

Phrase: "in addition to its antioxidant effect,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3179302:Anti-Oxidant Effect [Physiologic Function]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "contribute to reduction of oxidative damage,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0010957:Damage [Injury or Poisoning]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0311404:Oxidative [Functional Concept]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]
   753   C1880177:Contribute [Activity]
   753   C1883709:Damage [Functional Concept]

Phrase: "especially in liver."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0023884:Liver [Body Part, Organ, or Organ Component]
   790   C0736268:LIVER [Body Part, Organ, or Organ Component]
   790   C1278929:Liver [Body Part, Organ, or Organ Component]
   790   C2346688:LIVER [Food]
   734 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.181: Although we did not measure the lipid profile in this study, epidemiological studies suggest that hypertriglyceridemia rather than hyperglycemia is more associated with lipid peroxidation (28). 

Phrase: "Although"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the lipid profile in this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1979963:Profile [Laboratory Procedure]
   753   C2003903:Profile [Functional Concept]

Phrase: "epidemiological studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0002783:Epidemiological Studies [Research Activity]
   861   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   789 E C0014508:epidemiology [Functional Concept]
   789 E C0699910:epidemiology [Health Care Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that hypertriglyceridemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020557:Hypertriglyceridaemia [Finding]
  1000   C1522137:Hypertriglyceridemia [Finding]

Phrase: "rather than"

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "is"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "associated with lipid peroxidation"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0023775:Lipid Peroxidation [Molecular Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0023779:Lipid [Lipid]
   770   C0178796:peroxidation [Phenomenon or Process]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.182: However, the mechanism behind this differential effect of probucol in different organs remains to be investigated. 

Phrase: "However,"

Phrase: "the mechanism behind this differential effect of probucol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "in different organs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178784:organs [Body Part, Organ, or Organ Component]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.183: Although there is no doubt that hyperglycemia is a major contributor to oxidative stress, there have been some debate on the association between the glycemic control index and levels of 8-OHdG or 8-OHG. 

Phrase: "Although"

Phrase: "there"

Phrase: "is"

Phrase: "no doubt"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870444:doubt [Mental Process]
   928 E C0750558:Doubtful [Conceptual Entity]

Phrase: "that hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "is"

Phrase: "a major contributor to oxidative stress,"

Phrase: "there"

Phrase: "have"

Phrase: "been"

Phrase: "some debate on the association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0870392:debate [Activity]

Phrase: "between the glycemic control index"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1136206:Glycemic Index [Quantitative Concept]
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "and"

Phrase: "levels of 8-OHdG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "8-OHG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.184: Leinonen et al. 

Phrase: "Leinonen et al."
Processing 00000000.tx.185: (14) showed a positive association of HbA1c and urinary 8-OHdG in diabetic patients. 

Phrase: "(14"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a positive association of HbA1c"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "urinary 8-OHdG in diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.186: However, in our previous study, there was no significant correlation between HbA1c and plasma 8-OHG (24). 

Phrase: "However,"

Phrase: "in our previous study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "there"

Phrase: "was"

Phrase: "no significant correlation between HbA1c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.187: In this study, the levels of plasma 8-OHG and tissue 8-OHdG were not significantly correlated with average plasma glucose levels during the treatment period, although kidney 8-OHdG levels showed a tendency of association with blood glucose levels. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the levels of plasma 8-OHG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "tissue 8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "correlated with average plasma glucose levels"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   820   C0455280:glucose levels plasma [Laboratory or Test Result]
           plasma glucose
   790   C0202042:Plasma glucose [Laboratory Procedure]
   790   C0428548:glucose levels [Laboratory or Test Result]
   756 E C0337438:glucose level [Laboratory Procedure]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0032105:Plasma [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1510992:Average [Quantitative Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1707520:Correlated [Qualitative Concept]
   753   C2825518:AVERAGE [Quantitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "during the treatment period,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "although"

Phrase: "kidney 8-OHdG levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a tendency of association"

Phrase: "with blood glucose levels."
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.188: These discrepancies may imply that various factors other than hyperglycemia involve oxidative DNA damage in the diabetic state. 

Phrase: "These discrepancies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1290905:discrepancies [Finding]

Phrase: "may"

Phrase: "imply"

Phrase: "that various factors other than hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "involve"

Phrase: "oxidative DNA damage in the diabetic state."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   748   C0010957:Damage [Injury or Poisoning]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1883709:Damage [Functional Concept]
Processing 00000000.tx.189: Oxidative modifications of long-lived proteins such as collagen are associated with the development of diabetic complications (e.g., cataracts, microangiopathy, atherosclerosis, and nephropathy) (3). 

Phrase: "Oxidative modifications of long-lived proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C0033666:Protein Modification [Molecular Function]
   750   C2263112:protein modification [Molecular Function]
   719   C0392747:Modification [Functional Concept]
   719   C1554963:modification [Qualitative Concept]

Phrase: "such as collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "are"

Phrase: "associated with the development of diabetic complications"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C0342257:Diabetic Complications [Pathologic Function]
   748   C0009566:Complications [Pathologic Function]
   748   C0241863:DIABETIC [Finding]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1171258:complications [Pathologic Function]
   748   C1527148:Development [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
   714 E C2362589:Complication [Idea or Concept]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "cataracts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086543:CATARACTS [Anatomical Abnormality]
  1000   C0521707:Cataracts [Acquired Abnormality]

Phrase: "microangiopathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0155765:Microangiopathy [Disease or Syndrome]

Phrase: "atherosclerosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "and"

Phrase: "nephropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022658:Nephropathy [Disease or Syndrome]

Phrase: ")"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.190: However, it is as yet uncertain whether oxidative damage of DNA is directly related to the development of chronic diabetic complications. 

Phrase: "However,"

Phrase: "it"

Phrase: "is as yet uncertain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0087130:Uncertain [Idea or Concept]

Phrase: "whether"

Phrase: "oxidative damage of DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   770   C0010957:Damage [Injury or Poisoning]
   770   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "related to the development of chronic diabetic complications."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0342257:Diabetic Complications [Pathologic Function]
   744   C0009566:Complications [Pathologic Function]
   744   C0205191:chronic [Temporal Concept]
   744   C0241863:DIABETIC [Finding]
   744   C0243107:development [Physiologic Function]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C0678723:Development [Organism Function]
   744   C1171258:complications [Pathologic Function]
   744   C1527148:Development [Functional Concept]
   711 E C0163712:Relate [Organic Chemical]
   711 E C2362589:Complication [Idea or Concept]
Processing 00000000.tx.191: In the present study, we have shown a correlation between plasma 8-OHG and tissue 8-OHdG. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a correlation between plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "tissue 8-OHdG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.192: This suggests that plasma 8-OHG may be a useful biomarker for the assessment of oxidative DNA damage in diabetic patients. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that plasma 8-OHG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "may"

Phrase: "be"

Phrase: "a useful biomarker for the assessment of oxidative DNA damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0005516:Biomarker [Clinical Attribute]

Phrase: "in diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.193: In addition, our data suggests that combined treatment of insulin and antioxidants would be helpful for the reduction of oxidative stress in diabetes.  

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that combined treatment of insulin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0009429:combined treatment [Therapeutic or Preventive Procedure]
   806   C1704537:Combined Treatment [Therapeutic or Preventive Procedure]
   797   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "would"

Phrase: "be"

Phrase: "helpful for the reduction of oxidative stress"

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.194: ACKNOWLEDGMENTS  This work was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare (Grant no. HMP-96-M-3-1049). 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by a grant"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0018173:Grant [Quantitative Concept]
   770   C1521721:Supported [Conceptual Entity]
   770   C1548284:Grant [Idea or Concept]
   737 E C0183683:Support [Medical Device]

Phrase: "from the Korea Health 21 R&D Project,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1709701:Project [Conceptual Entity]

Phrase: "Ministry of Health & Welfare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037440:welfare [Self-help or Relief Organization]

Phrase: "(Grant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "no. HMP-96-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416423:HMP [Gene or Genome]

Phrase: "M-"

Phrase: "3-1049"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.195: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.196: Chan Soo Shin for helpful discussion.  

Phrase: "Chan Soo Shin for helpful discussion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0230444:Shin [Body Location or Region]
Processing 00000000.tx.197: FOOTNOTES  Address correspondence and reprint requests to Hong Kyu Lee, Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul 110-744, Korea. 

Phrase: "FOOTNOTES  Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0686900:request [Functional Concept]
  1000   C1272683:Request [Functional Concept]
  1000   C1522634:Request [Intellectual Product]

Phrase: "to Hong Kyu Lee,"

Phrase: "Department of Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Seoul National University College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0557806:College [Manufactured Object]

Phrase: "28 Yongon-Dong,"

Phrase: "Chongno-Gu,"

Phrase: "Seoul 110-744,"

Phrase: "Korea."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]
Processing 00000000.tx.198: E-mail: hkleemd{at}plaza.snu.ac.kr . Received for publication 21 March 2001 and accepted in revised form 14 September 2001. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "hkleemd{at}plaza.snu.ac.kr ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0022773:KR [Geographic Area]

Phrase: "Received for publication 21 March 2001"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and"

Phrase: "accepted in revised form 14 September 2001."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.199: CR, control rats; 

Phrase: "CR,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.200: dG, deoxyguanosine; 

Phrase: "dG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "deoxyguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.201: DR, diabetic rats; 

Phrase: "DR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: ";"
Processing 00000000.tx.202: DR+I, DR with insulin treatment; 

Phrase: "DR+I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "DR with insulin treatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0421248:diabetic insulin [Finding]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0241863:DIABETIC [Finding]

Phrase: ";"
Processing 00000000.tx.203: DR+I/E, DR+I with vitamin E treatment; 

Phrase: "DR+I/E, DR+I"

Phrase: "with vitamin E treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]

Phrase: ";"
Processing 00000000.tx.204: DR+I/P, DR+I with probucol treatment; 

Phrase: "DR+I/P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "DR+I with probucol treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.205: HPLC, high-performance liquid chromatography; 

Phrase: "HPLC,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
  1000   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
  1000   C1579831:High performance liquid chromatography [Functional Concept]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0597198:Performance [Individual Behavior]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C1882330:Performance [Activity]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]

Phrase: "high-performance liquid chromatography"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
  1000   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
  1000   C1579831:High performance liquid chromatography [Functional Concept]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0597198:Performance [Individual Behavior]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C1882330:Performance [Activity]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]

Phrase: ";"
Processing 00000000.tx.206: I/E, insulin and vitamin E treatment; 

Phrase: "I/E, insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "and"

Phrase: "vitamin E treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]

Phrase: ";"
Processing 00000000.tx.207: 8-OHdG, 8-hydroxydeoxyguanosine; 

Phrase: "8-OHdG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "8-hydroxydeoxyguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.208: 8-OHG, 8-hydroxyguanine; 

Phrase: "8-OHG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "8-hydroxyguanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.209: ROS, reactive oxygen species; 

Phrase: "ROS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.210: STZ, streptozotocin.  

Phrase: "STZ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "streptozotocin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
Processing 00000000.tx.211: REFERENCES TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Oberley LW: Free radicals and diabetes. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Oberley LW"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415842:LW [Gene or Genome]

Phrase: ":"

Phrase: "Free radicals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "and"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.212: Free Radic Biol Med 5:113124, 1988[Medline] Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic complications (Review). 

Phrase: "Free Radic Biol Med 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332296:free [Functional Concept]
   804   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]

Phrase: ":"

Phrase: "113124,"

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Giugliano D,"

Phrase: "Ceriello A,"

Phrase: "Paolisso G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "diabetic complications"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0342257:Diabetic Complications [Pathologic Function]
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]

Phrase: "(Review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.213: Diabetes Care 19:257267, 1996[Abstract] Baynes JW: Role of oxidative stress in development of complications in diabetes (Review). 

Phrase: "Diabetes Care 19"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C1947933:Care [Activity]

Phrase: ":"

Phrase: "257267,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Baynes JW"

Phrase: ":"

Phrase: "Role of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of complications"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009566:Complications [Pathologic Function]
  1000   C1171258:complications [Pathologic Function]
   966 E C2362589:Complication [Idea or Concept]
   916 E C0231242:Complicated [Functional Concept]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.214: Diabetes 40:405412, 1991[Abstract] Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. 

Phrase: "Diabetes 40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "405412,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Nishikawa T,"

Phrase: "Edelstein D,"

Phrase: "Du XL,"

Phrase: "Yamagishi S,"

Phrase: "Matsumura T,"

Phrase: "Kaneda Y,"

Phrase: "Yorek MA,"

Phrase: "Beebe D,"

Phrase: "Oates PJ,"

Phrase: "Hammes HP,"

Phrase: "Giardino I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Brownlee M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Normalizing mitochondrial superoxide production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033268:production [Occupational Activity]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "three pathways of hyperglycemic damage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.215: Nature 404:787790, 2000[Medline] Betteridge DJ: What is oxidative stress? 

Phrase: "Nature 404"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "787790,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Betteridge DJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: ":"

Phrase: "What"

Phrase: "is"

Phrase: "oxidative stress?"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.216: (Review) Metabolism49 (Suppl. 1):38, 2000 Wolff SP, Jiang ZY, Hunt JV: Protein glycation and oxidative stress in diabetes mellitus and aging. 

Phrase: "(Review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: ")"

Phrase: "Metabolism49"

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "38,"

Phrase: "2000 Wolff SP,"

Phrase: "Jiang ZY,"

Phrase: "Hunt JV"

Phrase: ":"

Phrase: "Protein glycation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598528:glycation [Phenomenon or Process]

Phrase: "and"

Phrase: "oxidative stress in diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]

Phrase: "and"

Phrase: "aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]
Processing 00000000.tx.217: Free Radic Biol Med 10:339352, 1991[Medline] Shigenaga MK, Gimeno CJ, Ames BN: Urinary 8-hydroxy-2'deoxy guanosine as a biologic marker of in vivo oxidative DNA damage. 

Phrase: "Free Radic Biol Med 10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332296:free [Functional Concept]
   804   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]

Phrase: ":"

Phrase: "339352,"

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shigenaga MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Gimeno CJ,"

Phrase: "Ames BN"

Phrase: ":"

Phrase: "Urinary 8-hydroxy-2'deoxy guanosine as a biologic marker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   739   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "of in vivo oxidative DNA damage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   804   C0010957:Damage [Injury or Poisoning]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1883709:Damage [Functional Concept]
Processing 00000000.tx.218: Proc Natl Acad Sci U S A 86:96979701, 1989[Abstract] Richter C, Park JW, Ames BN: Normal oxidative damage to mitochondrial and nuclear DNA is extensive. 

Phrase: "Proc Natl Acad Sci U S A 86"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "96979701,"

Phrase: "1989"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Richter C,"

Phrase: "Park JW,"

Phrase: "Ames BN"

Phrase: ":"

Phrase: "Normal oxidative damage to mitochondrial"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1096176:Mitochondrial Damage [Pathologic Function]
   760   C0010957:Damage [Injury or Poisoning]
   760   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "nuclear DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "is"

Phrase: "extensive."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205231:Extensive [Qualitative Concept]
   928 E C0439795:Extensiveness [Qualitative Concept]
Processing 00000000.tx.219: Proc Natl Acad Sci U S A 85:64656467, 1988[Abstract] Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN: Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine. 

Phrase: "Proc Natl Acad Sci U S A 85"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "64656467,"

Phrase: "1988"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Fraga CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Shigenaga MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Park JW,"

Phrase: "Degan P,"

Phrase: "Ames BN"

Phrase: ":"

Phrase: "Oxidative damage to DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   770   C0010957:Damage [Injury or Poisoning]
   770   C1883709:Damage [Functional Concept]

Phrase: "during aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: ":"

Phrase: "8-hydroxy-2'-deoxyguanosine in rat organ DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "urine."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042036:Urine [Body Substance]
  1000   C0042037:urine [Functional Concept]
  1000   C2963137:Urine [Body Substance]
Processing 00000000.tx.220: Proc Natl Acad Sci U S A 87:45334537, 1990[Abstract] Kasai H, Crain PF, Kuchino Y, Nishimura S, Ootsuyama A, Tanooka H: Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. 

Phrase: "Proc Natl Acad Sci U S A 87"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "45334537,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kasai H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Crain PF,"

Phrase: "Kuchino Y,"

Phrase: "Nishimura S,"

Phrase: "Ootsuyama A,"

Phrase: "Tanooka H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Formation of 8-hydroxyguanine moiety"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "in cellular DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "by agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "producing"

Phrase: "oxygen radicals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0162772:Oxygen Radicals [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0302912:radicals [Chemical Viewed Structurally]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "and"

Phrase: "evidence for its repair."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.221: Carcinogenesis 7:18491851, 1986[Abstract] Tchou J, Kasai H, Shibutani S, Chung MH, Laval J, Grollman AP, Nishimura S: 8-Oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. 

Phrase: "Carcinogenesis 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596263:Carcinogenesis [Neoplastic Process]

Phrase: ":"

Phrase: "18491851,"

Phrase: "1986"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tchou J,"

Phrase: "Kasai H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Shibutani S,"

Phrase: "Chung MH,"

Phrase: "Laval J,"

Phrase: "Grollman AP,"

Phrase: "Nishimura S"

Phrase: ":"

Phrase: "8-Oxoguanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0167195:8-oxoguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(8-hydroxyguanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050091:8-hydroxyguanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "DNA glycosylase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0114612:DNA glycosylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1817832:glycosylase [Molecular Function]

Phrase: "and"

Phrase: "its substrate specificity."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0038592:Substrate Specificity [Quantitative Concept]
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   861   C1710236:Substrate [Manufactured Object]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.222: Proc Natl Acad Sci U S A 88:46904694, 1991[Abstract] Chung MH, Kim HS, Ohtsuka E, Kasai H, Yamamoto F, Nishimura S: An endonuclease activity in human polymorphonuclear neutrophils that removes 8-hydroxyguanine residues from DNA. 

Phrase: "Proc Natl Acad Sci U S A 88"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "46904694,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chung MH,"

Phrase: "Kim HS,"

Phrase: "Ohtsuka E,"

Phrase: "Kasai H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yamamoto F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Nishimura S"

Phrase: ":"

Phrase: "An endonuclease activity in human polymorphonuclear neutrophils"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1148807:endonuclease activity [Genetic Function]
   774   C0020115:Human Activity [Activity]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "removes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "8-hydroxyguanine residues from DNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.223: Biochem Biophys Res Commun 178:14721478, 1991[Medline] Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T: Oxidative damage to DNA in diabetes mellitus. 

Phrase: "Biochem Biophys Res Commun 178"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "14721478,"

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dandona P,"

Phrase: "Thusu K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Cook S,"

Phrase: "Snyder B,"

Phrase: "Makowski J,"

Phrase: "Armstrong D,"

Phrase: "Nicotera T"

Phrase: ":"

Phrase: "Oxidative damage to DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   770   C0010957:Damage [Injury or Poisoning]
   770   C1883709:Damage [Functional Concept]

Phrase: "in diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.224: Lancet 347:444445, 1996[Medline] Leinonen J, Lehtimaki T, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Laippala P, Rantalaiho V, Wirta O, Pasternack A, Alho H: New biomarker evidence of oxidative damage in patients with non-insulin-dependent diabetes mellitus. 

Phrase: "Lancet 347"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "444445,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Leinonen J,"

Phrase: "Lehtimaki T,"

Phrase: "Toyokuni S,"

Phrase: "Okada K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tanaka T,"

Phrase: "Hiai H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ochi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Laippala P,"

Phrase: "Rantalaiho V,"

Phrase: "Wirta O,"

Phrase: "Pasternack A,"

Phrase: "Alho H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "New biomarker evidence of oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with non-insulin-dependent diabetes mellitus."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.225: FEBS Lett 417:150152, 1997[Medline] Krapfenbauer K, Birnbacher R, Vierhapper H, Herkner K, Kampel D, Lubec G: Glycoxidation, and protein and DNA oxidation in patients with diabetes mellitus. 

Phrase: "FEBS Lett 417"

Phrase: ":"

Phrase: "150152,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Krapfenbauer K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Birnbacher R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Vierhapper H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Herkner K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kampel D,"

Phrase: "Lubec G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Glycoxidation,"

Phrase: "and"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "DNA oxidation in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "with diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.226: Clin Sci (Lond)95:331337, 1998[Medline] Ha H, Kim C, Son YS, Chung MH, Kim KH: DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. 

Phrase: "Clin Sci (Lond)95"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1315013:CLIN [Intellectual Product]
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "331337,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ha H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kim C,"

Phrase: "Son YS,"

Phrase: "Chung MH,"

Phrase: "Kim KH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: ":"

Phrase: "DNA damage in the kidneys of diabetic rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   744   C0010957:Damage [Injury or Poisoning]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1883709:Damage [Functional Concept]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "microalbuminuria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]
Processing 00000000.tx.227: Free Radic Biol Med 16:271274, 1994[Medline] Moller L, Hofer T: [32P]ATP mediates formation of 8-hydroxy-2'-deoxyguanosine from 2'-deoxyguanosine, a possible problem in the 32P-postlabeling assay. 

Phrase: "Free Radic Biol Med 16"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332296:free [Functional Concept]
   804   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]

Phrase: ":"

Phrase: "271274,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Moller L,"

Phrase: "Hofer T"

Phrase: ":"

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "formation of 8-hydroxy-2'-deoxyguanosine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1157283:deoxyguanosine formation [Molecular Function]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
   716   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "from 2'-deoxyguanosine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "a possible problem in the 32P-postlabeling assay."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033213:Problem [Finding]
Processing 00000000.tx.228: Carcinogenesis 18:24152419, 1997[Abstract] Shigenaga MK, Aboujaoude EN, Chen Q, Ames BN: Assays of oxidative DNA damage biomarker 8-oxo-2'-deoxyguanosine and 8-oxoguanosine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. 

Phrase: "Carcinogenesis 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596263:Carcinogenesis [Neoplastic Process]

Phrase: ":"

Phrase: "24152419,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shigenaga MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Aboujaoude EN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417861:eN [Gene or Genome]
   861   C2987294:EN [Qualitative Concept]

Phrase: "Chen Q,"

Phrase: "Ames BN"

Phrase: ":"

Phrase: "Assays of oxidative DNA damage biomarker 8-oxo-2'-deoxyguanosine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C0005507:Assay [Laboratory Procedure]
   706   C0243073:assay [Qualitative Concept]
   706   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "8-oxoguanosine in nuclear DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0050092:8-oxoguanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "biological fluids by high-performance liquid chromatography"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0005889:Fluids [Body Substance]
   748   C0302908:fluids [Substance]
   748   C1521806:Fluids [Tissue]
   714 E C0444611:Fluid [Qualitative Concept]
   714 E C1704353:Fluid [Substance]

Phrase: "with electrochemical detection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.229: Methods Enzymol 234:1633, 1994[Medline] Helbock HJ, Beckman KB, Shigenaga MK, Walter PB, Woodall AA, Yeo HC, Ames BN: DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. 

Phrase: "Methods Enzymol 234"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "1633,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Helbock HJ,"

Phrase: "Beckman KB,"

Phrase: "Shigenaga MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Walter PB,"

Phrase: "Woodall AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Yeo HC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]

Phrase: "Ames BN"

Phrase: ":"

Phrase: "DNA oxidation matters"

Phrase: ":"

Phrase: "the HPLC-electrochemical detection assay"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0005507:Assay [Laboratory Procedure]
   795   C0243073:assay [Qualitative Concept]
   795   C1510438:Assay [Laboratory Procedure]
   710   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   710   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   710   C1579831:High performance liquid chromatography [Functional Concept]

Phrase: "of 8-oxo-deoxyguanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0393003:OXO [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "8-oxo-guanine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.230: Proc Natl Acad Sci U S A 95:288293, 1998[Abstract/Free FullText] Shigenaga MK, Park JW, Cundy KC, Gimeno CJ, Ames BN: In vivo oxidative damage: measurement of 8-hydroxy-2'-deoxyguanosine in DNA and urine by high performance liquid chromatography with electrochemical detection. 

Phrase: "Proc Natl Acad Sci U S A 95"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "288293,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shigenaga MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Park JW,"

Phrase: "Cundy KC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022575:kc [Disease or Syndrome]
   861   C1705783:KC [Gene or Genome]

Phrase: "Gimeno CJ,"

Phrase: "Ames BN"

Phrase: ":"

Phrase: "In vivo oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0010957:Damage [Injury or Poisoning]
   812   C1883709:Damage [Functional Concept]

Phrase: ":"

Phrase: "measurement of 8-hydroxy-2'-deoxyguanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0242485:Measurement [Functional Concept]
   716   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "urine by high performance liquid chromatography"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C1271617:Urine chromatography [Laboratory Procedure]
   753   C0042036:Urine [Body Substance]
   753   C0042037:urine [Functional Concept]
   753   C2963137:Urine [Body Substance]
   716   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   716   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   716   C1579831:High performance liquid chromatography [Functional Concept]

Phrase: "with electrochemical detection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.231: Methods Enzymol 186:521530, 1990[Medline] Park EM, Shigenaga MK, Degan P, Korn TS, Kitzler JW, Wehr CM, Kolachana P, Ames BN: Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column. 

Phrase: "Methods Enzymol 186"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "521530,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Park EM,"

Phrase: "Shigenaga MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Degan P,"

Phrase: "Korn TS,"

Phrase: "Kitzler JW,"

Phrase: "Wehr CM,"

Phrase: "Kolachana P,"

Phrase: "Ames BN"

Phrase: ":"

Phrase: "Assay of excised oxidative DNA lesions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: ":"

Phrase: "isolation of 8-oxoguanine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0220862:isolation [Laboratory Procedure]

Phrase: "and"

Phrase: "its nucleoside derivatives from biological fluids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0243072:derivatives [Chemical Viewed Structurally]
   719 E C1527240:Derivative [Functional Concept]

Phrase: "with a monoclonal antibody column."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.232: Proc Natl Acad Sci U S A 89:33753379, 1992[Abstract] Ames BN: Endogenous oxidative DNA damage, aging, and cancer. 

Phrase: "Proc Natl Acad Sci U S A 89"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "33753379,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ames BN"

Phrase: ":"

Phrase: "Endogenous oxidative DNA damage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   812   C0010957:Damage [Injury or Poisoning]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1883709:Damage [Functional Concept]

Phrase: "aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: ","

Phrase: "and"

Phrase: "cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]
Processing 00000000.tx.233: Free Radic Res Commun 7:121128, 1989[Medline] Loft S, Vistisen K, Ewertz M, Tjonneland A, Overvad K, Poulsen HE: Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. 

Phrase: "Free Radic Res Commun 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0332296:free [Functional Concept]
   804   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "121128,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Loft S,"

Phrase: "Vistisen K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ewertz M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tjonneland A,"

Phrase: "Overvad K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Poulsen"

Phrase: "HE"

Phrase: ":"

Phrase: "Oxidative DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   827   C0010957:Damage [Injury or Poisoning]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1883709:Damage [Functional Concept]

Phrase: "estimated by 8-hydroxydeoxyguanosine excretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0050078:8-Hydroxydeoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0221102:Excretion [Physiologic Function]
   760   C0504085:Excretion [Body Substance]
   760   C0750572:Estimated [Quantitative Concept]
   760   C2699704:EXCRETION [Regulation or Law]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: ":"

Phrase: "influence of smoking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0021399:influential [Idea or Concept]

Phrase: "gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "and"

Phrase: "body mass index."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0005893:Body Mass Index [Diagnostic Procedure]
  1000   C1305855:Body mass index [Clinical Attribute]
   901   C0518010:body mass [Finding]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0577559:Mass [Finding]
   827   C0918012:Index [Intellectual Product]
   827   C1268086:Body [Anatomical Structure]
   827   C1306372:*Mass [Quantitative Concept]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]
   743 E C1995017:Bodies [Cell Component]
Processing 00000000.tx.234: Carcinogenesis 13:22412247, 1992[Abstract] Shin CS, Moon BS, Park KS, Kim SY, Park SJ, Chung MH, Lee HK: Serum 8-hydroxy-guanosine levels are increased in diabetic patients. 

Phrase: "Carcinogenesis 13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596263:Carcinogenesis [Neoplastic Process]

Phrase: ":"

Phrase: "22412247,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shin CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Moon BS,"

Phrase: "Park KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Kim SY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039138:SY [Geographic Area]
   861   C1706466:SY [Intellectual Product]

Phrase: "Park SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Chung MH,"

Phrase: "Lee HK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: ":"

Phrase: "Serum 8-hydroxy-guanosine levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased in diabetic patients."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205217:Increased [Quantitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0442805:Increased [Functional Concept]
Processing 00000000.tx.235: Diabetes Care 24:733737, 2001[Abstract/Free FullText] Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC: Vitamin E consumption and the risk of coronary disease in women. 

Phrase: "Diabetes Care 24"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C1947933:Care [Activity]

Phrase: ":"

Phrase: "733737,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stampfer MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Hennekens CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Manson JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Colditz GA,"

Phrase: "Rosner B,"

Phrase: "Willett WC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: ":"

Phrase: "Vitamin E consumption"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0009830:Consumption [Activity]
   827   C1947907:Consumption [Physiologic Function]
   734   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "the risk of coronary disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]
Processing 00000000.tx.236: N Engl J Med 328:14441449, 1993[Abstract/Free FullText] Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary disease in men. 

Phrase: "N Engl J Med 328"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "14441449,"

Phrase: "1993"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rimm EB,"

Phrase: "Stampfer MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Ascherio A,"

Phrase: "Giovannucci E,"

Phrase: "Colditz GA,"

Phrase: "Willett WC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: ":"

Phrase: "Vitamin E consumption"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0009830:Consumption [Activity]
   827   C1947907:Consumption [Physiologic Function]
   734   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "the risk of coronary disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in men."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]
Processing 00000000.tx.237: N Engl J Med 328:14501456, 1993[Abstract/Free FullText] Tardif JC, Cote G, Lesperance J, Bourassa M, Lambert J, Doucet S, Bilodeau L, Nattel S, de Guise P: Probucol and multivitamins in the prevention of restenosis after coronary angioplasty: Multivitamins and Probucol Study Group. 

Phrase: "N Engl J Med 328"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "14501456,"

Phrase: "1993"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tardif JC,"

Phrase: "Cote G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lesperance J,"

Phrase: "Bourassa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lambert J,"

Phrase: "Doucet S,"

Phrase: "Bilodeau L,"

Phrase: "Nattel S,"

Phrase: "de Guise P"

Phrase: ":"

Phrase: "Probucol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033215:Probucol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "multivitamins in the prevention of restenosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0301532:MULTIVITAMINS [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "after coronary angioplasty"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002997:coronary angioplasty [Therapeutic or Preventive Procedure]
  1000   C0190211:Coronary angioplasty [Therapeutic or Preventive Procedure]
   861   C0018787:coronary [Body Part, Organ, or Organ Component]
   861   C0162577:Angioplasty [Therapeutic or Preventive Procedure]
   861   C1548817:Angioplasty [Health Care Activity]

Phrase: ":"

Phrase: "Multivitamins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301532:MULTIVITAMINS [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "Probucol Study Group."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0441833:Group [Idea or Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.238: N Engl J Med 337:365372, 1997[Abstract/Free FullText] Stringer MD, Gorog PG, Freeman A, Kakkar VV: Lipid peroxides and atherosclerosis. 

Phrase: "N Engl J Med 337"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "365372,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stringer MD,"

Phrase: "Gorog PG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: "Freeman A,"

Phrase: "Kakkar VV"

Phrase: ":"

Phrase: "Lipid peroxides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023776:Lipid Peroxides [Lipid]
   861   C0023779:Lipid [Lipid]
   861   C0031180:Peroxides [Inorganic Chemical]

Phrase: "and"

Phrase: "atherosclerosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]
Processing 00000000.tx.239: BMJ 298:281284, 1989[Medline]

Phrase: "BMJ 298"

Phrase: ":"

Phrase: "281284,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

